{"protocolSection":{"identificationModule":{"nctId":"NCT04505722","orgStudyIdInfo":{"id":"CR108876"},"secondaryIdInfos":[{"id":"VAC31518COV3001","type":"OTHER","domain":"Janssen Vaccines & Prevention B.V."}],"organization":{"fullName":"Janssen Vaccines & Prevention B.V.","class":"INDUSTRY"},"briefTitle":"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants","officialTitle":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older","acronym":"ENSEMBLE"},"statusModule":{"statusVerifiedDate":"2025-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":true,"nctId":"NCT04817657","statusForNctId":"NO_LONGER_AVAILABLE"},"startDateStruct":{"date":"2020-09-07","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-03-31","type":"ACTUAL"},"completionDateStruct":{"date":"2023-03-31","type":"ACTUAL"},"studyFirstSubmitDate":"2020-07-31","studyFirstSubmitQcDate":"2020-08-07","studyFirstPostDateStruct":{"date":"2020-08-10","type":"ACTUAL"},"resultsFirstSubmitDate":"2022-01-25","resultsFirstSubmitQcDate":"2022-04-11","resultsFirstPostDateStruct":{"date":"2022-04-15","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-01-31","lastUpdatePostDateStruct":{"date":"2025-02-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Janssen Vaccines & Prevention B.V.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study will evaluate the efficacy of Ad26.COV2.S in the prevention of molecularly confirmed moderate to severe/critical COVID-19, as compared to placebo, in adult participants."},"conditionsModule":{"conditions":["Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol"],"keywords":["Prevention","Vaccine"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":44325,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Ad26.COV2.S","type":"EXPERIMENTAL","description":"Participants will receive intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1. At Year 1 (booster visit), participants who previously received any coronavirus disease-2019 (COVID-19) vaccination (as primary regimen or additional dose) will be offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level.","interventionNames":["Biological: Ad26.COV2.S"]},{"label":"Placebo","type":"EXPERIMENTAL","description":"Participants will receive IM injection of placebo on Day 1. At Month 6/unblinding visit, post Emergency Use Authorization (EUA), conditional licensure, or approval for the single dose regimen, participants initially receiving placebo will be offered to receive a single dose of Ad26.COV2.S vaccine IM at a dose level of 5\\*10\\^10 vp. At Year 1 (booster visit), participants who previously received any COVID-19 vaccination (as primary regimen or additional dose) will be offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level.","interventionNames":["Biological: Ad26.COV2.S","Other: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Ad26.COV2.S","description":"Ad26.COV2.S will be administered at a single dose of 5\\*10\\^10 virus particles (vp) on Day 1 (or Month 6 for placebo recipients) and as a single booster dose at Year 1.","armGroupLabels":["Ad26.COV2.S","Placebo"],"otherNames":["JNJ-78436735","Ad26COVS1"]},{"type":"OTHER","name":"Placebo","description":"Participants will receive Placebo.","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical Coronavirus Disease (COVID-19) With Seronegative Status With Onset at Least 14 Days After Double-blind Vaccination on Day 1 (Day 15): Double-blind Phase","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positive reverse transcription/polymerase chain reaction (RT-PCR) or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, oxygen saturation (SpO2) \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"From 14 days after double-blind vaccination on Day 1 (Day 15) up to Month 6"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 With Seronegative Status With Onset at Least 28 Days After Double-blind Vaccination on Day 1 (Day 29): Double-blind Phase","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>=20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats/minute and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 less than or equal to (\\<=) 93 percent (%) on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the Intensive Care Unit (ICU), death defined as per Food and Drug Administration (FDA) guidance.","timeFrame":"From 28 days after double-blind vaccination on Day 1 (Day 29) up to Month 6"},{"measure":"Number of Participants With Solicited Local Adverse Events (AEs) Up to 7 Days After Booster Vaccination (Open-label Booster Vaccination Phase)","description":"Participants who received the booster dose were asked to note in the e-Diary occurrences of injection site pain/tenderness, erythema, and swelling at the study vaccine injection site daily for 7 days post-booster vaccination (day of vaccination and the subsequent 7 days).","timeFrame":"Up to Day 372 (7 Days after booster vaccination on Day 365 [Year 1])"},{"measure":"Number of Participants With Solicited Systemic AEs Up to 7 Days After Booster Vaccination (Open-label Booster Vaccination Phase)","description":"Participants recorded the temperature in the e-Diary in the evening of the day of vaccination, and then daily for the next 7 days approximately at the same time each day. If more than 1 measurement was made on any given day, the highest temperature of that day was recorded in the e-Diary. Fever was defined as endogenous elevation of body temperature \\>= 38.0 degree Celsius or \\>=100.4-degree Fahrenheit, as recorded in at least 1 measurement. Participants also noted the signs and symptoms in the e-Diary on a daily basis for 7 days post-booster vaccination (day of vaccination and the subsequent 7 days), if feasible, for the following events: fatigue, headache, nausea, myalgia.","timeFrame":"Up to Day 372 (7 Days after booster vaccination on Day 365 [Year 1])"},{"measure":"Number of Participants With Unsolicited AEs Up to 28 Days After Booster Vaccination (Open-label Booster Vaccination Phase)","description":"Unsolicited AEs were all AEs for which the participant is not specifically questioned in the participant diary.","timeFrame":"Up to Day 393 (28 Days after booster vaccination on Day 365 [Year 1])"}],"secondaryOutcomes":[{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Severe/Critical COVID-19 With Seronegative Status With Onset at Least 14 Days After Double-blind Vaccination on Day 1 (Day 15): Double-blind Phase","description":"Molecularly confirmed severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance. Seronegative is defined as N-serology seronegative at the time of boosting or at the Year 1 visit if not boosted.","timeFrame":"From 14 days after double-blind vaccination on Day 1 (Day 15) up to Month 6"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Severe/Critical COVID-19 With Seronegative Status With Onset at Least 28 Days After Double-blind Vaccination on Day 1 (Day 29): Double-blind Phase","description":"Severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"From 28 days after double-blind vaccination on Day 1 (Day 29) up to Month 6"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Their Serostatus (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"1 day after double-blind vaccination on Day 1 (Day 2)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Their Serostatus (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"14 days after double-blind vaccination on Day 1 (Day 15)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Their Serostatus (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","timeFrame":"28 days after double-blind vaccination on Day 1 (Day 29)"},{"measure":"Number of Participants With First Occurrence of COVID-19 Requiring Medical Intervention (Double Blind Phase)","description":"Number of participants with first occurrence of COVID-19 requiring medical intervention (such as a composite endpoint of hospitalization, ICU admission, mechanical ventilation, and extracorporeal membrane oxygenation \\[ECMO\\], linked to objective measures such as decreased oxygenation, X-ray or computed tomography \\[CT\\] findings) or linked to any molecularly confirmed, COVID-19 at least 14 days post vaccination were reported.","timeFrame":"14 days after double-blind vaccination on Day 1 (Day 15)"},{"measure":"Number of Participants With First Occurrence of COVID-19 Requiring Medical Intervention (Double Blind Phase)","description":"Number of participants with first occurrence of COVID-19 requiring medical intervention (such as a composite endpoint of hospitalization, ICU admission, mechanical ventilation, and ECMO, linked to objective measures such as decreased oxygenation, X-ray or CT findings) or linked to any molecularly confirmed, COVID-19 at least 28 days post vaccination were reported.","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)"},{"measure":"Area Under the Curve (AUC) of SARS-CoV-2 Viral Load as Assessed by Quantitative Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) in Participants With Molecularly Confirmed, Moderate to Severe/Critical COVID-19 (Double Blind Phase)","description":"AUC of SARS-CoV-2 Viral Load was assessed in confirmed COVID-19 cases using RT-PCR. Nasal swabs were used to detect and/or quantify SARS-CoV-2.","timeFrame":"From Day 15 to end of the COVID-19 episode (Day 189)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Mild COVID-19 (Double Blind Phase","description":"Molecularly confirmed mild Covid-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: fever (\\>=38°C or \\>=100.4°F), sore throat, malaise (loss of appetite, generally unwell, fatigue, physical weakness), headache, muscle pain (myalgia), gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, new or changing olfactory or taste disorders, red or bruised looking feet or toes, or shaking chills or rigors.","timeFrame":"14 Days after double-blind vaccination on Day1 (Day 15)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed Mild COVID-19 (Double Blind Phase)","description":"Molecularly confirmed mild Covid-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: fever (\\>=38°C or \\>=100.4°F), sore throat, malaise (loss of appetite, generally unwell, fatigue, physical weakness), headache, muscle pain (myalgia), gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, new or changing olfactory or taste disorders, red or bruised looking feet or toes, or shaking chills or rigors.","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US Food and Drug Administration (FDA) Harmonized Case Definition (Double Blind Phase)","description":"Molecularly confirmed COVID-19 was defined as a positive SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample; and COVID-19 symptoms consistent with those defined by the US FDA harmonized case definition at the time of finalization of the study protocol: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, diarrhea.","timeFrame":"14 Days after double-blind vaccination on Day 1 (Day 15)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US Food and Drug Administration (FDA) Harmonized Case Definition (Double Blind Phase)","description":"Molecularly confirmed COVID-19 was defined as a positive SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample; and COVID-19 symptoms consistent with those defined by the US FDA harmonized case definition at the time of finalization of the study protocol: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, diarrhea.","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)"},{"measure":"Number of Participants With Burden of Disease (BOD) Based on First Occurrence of Molecularly Confirmed Symptomatic COVID-19 (Double Blind Phase)","description":"BOD is a weighted version of the mild, moderate, and severe/critical vaccine efficacies and was evaluated based on the first occurrence of molecularly confirmed COVID-19, including mild, moderate or severe/critical COVID-19 case.","timeFrame":"14 Days after double-blind vaccination on Day 1 (Day 15)"},{"measure":"Number of Participants With BOD Based on First Occurrence of Molecularly Confirmed Symptomatic COVID-19 (Double Blind Phase)","description":"BOD is a weighted version of the mild, moderate, and severe/critical vaccine efficacies and was evaluated based on the first occurrence of molecularly confirmed COVID-19, including mild, moderate or severe/critical COVID-19 case.","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)"},{"measure":"Number of Participants With SARS-CoV-2 Seroconversion Based on Antibodies to N Protein Using ELISA and/or SARS-CoV-2 Immunoglobulin Assay (Double Blind Phase)","description":"Number of participants with SARS-CoV-2 seroconversion based on antibodies to nucleocapsid (N) protein using enzyme-linked immunosorbent assay (ELISA) and/or SARS-CoV- 2 immunoglobulin assay that is dependent on the SARS-CoV-2 N protein was reported.","timeFrame":"From Day 29 until end of double-blind phase at Month 6"},{"measure":"Number of Participants With Asymptomatic Infection Detected by RT-PCR at the Time of the Month 6/Unblinding Visit (Double Blind Phase)","description":"Number of participants with asymptomatic infection detected by RT-PCR at the time of the Month 6/unblinding visit were reported.","timeFrame":"Month 6"},{"measure":"Number of Participants With First Occurrence of SARS-CoV-2 Infection (Serologically and/or Molecularly Confirmed) (Double Blind Phase)","description":"Number of participants with first occurrence of SARS-CoV-2 infection (serologically and/or molecularly confirmed) were reported.","timeFrame":"28 days after double-blind vaccination on Day 1 (Day 29)"},{"measure":"Number of Participants With First Occurrence of Molecularly Confirmed, Moderate to Severe/Critical COVID-19 for Seronegative Participants (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance. Seronegative is defined as N-serology seronegative at the time of boosting or at the Year 1 visit if not boosted.","timeFrame":"1 day after double-blind vaccination on Day 1 (Day 2)"},{"measure":"Number of Participants With Serious Adverse Events (SAEs) (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. SAE is any untoward medical occurrence that at any dose may result in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product.","timeFrame":"Baseline (Day 1) up to 35 weeks"},{"measure":"Number of Participants With Adverse Events of Special Interest (AESI) (Double Blind Phase)","description":"Number of participants with AESIs were reported. AESIs are significant AEs that are judged to be of special interest because of clinical importance, known or suspected class effects, or based on nonclinical signals. Thrombosis with Thrombocytopenia Syndrome (TTS), a syndrome characterized by a combination of both a thrombotic event and thrombocytopenia, is considered to be an AESI in this study. A suspected TTS case is defined as: Thrombotic events: suspected deep vessel venous or arterial thrombotic events; Thrombocytopenia, defined as platelet count below 150,000/micro liter.","timeFrame":"Baseline (Day 1) up to 35 weeks"},{"measure":"Number of Participants With Medically-Attended Adverse Events (MAAEs) (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason.","timeFrame":"Up to 6 months after double-blind vaccination on Day 1 (up to 6 months)"},{"measure":"Number of Participants With MAAEs Leading to Study Discontinuation (Double Blind Phase)","description":"MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason. Routine study visits were not considered medically-attended visits. New onset of chronic diseases was collected as part of the MAAEs.","timeFrame":"Up to 35 weeks"},{"measure":"Number of Participants With Solicited Local Adverse Events (AEs) During 7 Days Following Vaccination (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. Participants who were enrolled in safety subset were asked to note in the e-Diary occurrences of injection site pain/tenderness, erythema, and swelling at the study vaccine injection site daily for 7 days post-vaccination (day of vaccination and the subsequent 7 days).","timeFrame":"Up to Day 8 (7 Days after double-blind vaccination on Day 1)"},{"measure":"Number of Participants With Solicited Systemic AEs During 7 Days Following Vaccination (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with pharmaceutical/biological agent under study. Participants who were enrolled in safety subset were instructed on how to record daily temperature using a thermometer provided for home use. Participants recorded the temperature in the e-Diary in the evening of the day of vaccination, and then daily for the next 7 days approximately at the same time each day. If more than 1 measurement was made on any given day, the highest temperature of that day was recorded in the e-Diary. Fever was defined as endogenous elevation of body temperature \\>= 38.0 degree Celsius or \\>=100.4-degree Fahrenheit, as recorded in at least 1 measurement. Participants also noted the signs and symptoms in the e-Diary on a daily basis for 7 days post vaccination (day of vaccination and the subsequent 7 days), for the following events: fatigue, headache, nausea, myalgia.","timeFrame":"Up to Day 8 (7 Days after double-blind vaccination on Day 1)"},{"measure":"Number of Participants With Unsolicited AEs During 28 Days Post-vaccination (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. Unsolicited AEs were all AEs for which the participant is not specifically questioned in the participant diary.","timeFrame":"Up to Day 29 (28 Days after double-blind vaccination on Day 1)"},{"measure":"Binding Antibodies to SARS-CoV-2 S Protein Assessed by ELISA (Double Blind Phase)","description":"Binding antibodies to SARS-CoV-2 S protein as assessed by enzyme-linked immunosorbent assay (ELISA) to measure humoral immune response was reported. The lower limit of quantification (LLOQ) and upper limit of quantification (ULOQ) were 50.3 EU/mL and 58,158.10 EU/mL, respectively. A sample was considered positive if the value was strictly greater than the LLOQ (\\>LLOQ).","timeFrame":"Baseline (Day 1), Day 29, and Day 71"},{"measure":"Number of Participants With Antibody Titers to Ad26.COV2.S (Booster Phase)","description":"Number of participants with antibody titers to Ad26.COV2.S to measure immune response were reported.","timeFrame":"28 days after booster vaccination on Day 365 (up to Day 393)"},{"measure":"Number of Participants With Binding Antibodies to SARS- CoV-2S Protein as Measured by ELISA (Booster Phase)","description":"Number of participants with binding antibodies to SARS- CoV-2S protein as measured by ELISA was reported.","timeFrame":"29 days after booster vaccination on Day 365 (Day 394)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Contraceptive (birth control) use should be consistent with local regulations regarding the acceptable methods of contraception for those participating in clinical studies\n* All participants of childbearing potential must: have a negative highly sensitive urine pregnancy test at screening; and have a negative highly sensitive urine pregnancy test immediately prior to each study vaccine administration\n* Participant agrees to not donate bone marrow, blood, and blood products from the first study vaccine administration until 3 months after receiving the last dose of study vaccine\n* Must be willing to provide verifiable identification, has means to be contacted and to contact the investigator during the study\n* Must be able to read, understand, and complete questionnaires in the electronic clinical outcome assessment (eCOA) (that is, the coronavirus disease-2019 \\[COVID 19\\] signs and symptoms surveillance question, the e-Diary, and the electronic patient-reported outcomes (ePROs). Note: Participants with visual impairment are eligible for study participation and may have caregiver assistance in completing the electronic clinical outcome assessment (eCOA) questionnaires\n\nExclusion Criteria:\n\n* Participant has a clinically significant acute illness (this does not include minor illnesses such as diarrhea or mild upper respiratory tract infection) or temperature greater than or equal to (\\>=) 38.0 degree Celsius (100.4-degree Fahrenheit) within 24 hours prior to the planned first dose of study vaccine; randomization at a later date is permitted at the discretion of the investigator and after consultation with the sponsor\n* Participant received or plans to receive: (a) licensed live attenuated vaccines - within 28 days before or after planned administration of study vaccine ; and (b) other licensed (not live) vaccines - within 14 days before or after planned administration of study vaccine\n* Participant previously received a coronavirus vaccine\n* Participant received an investigational drug (including investigational drugs for prophylaxis of COVID-19) within 30 days or used an invasive investigational medical device within 30 days or received investigational immunoglobulin (Ig) or monoclonal antibodies within 3 months, or received convalescent serum for COVID-19 treatment within 4 months or received an investigational vaccine (including investigational Adenoviral-vectored vaccines) within 6 months before the planned administration of the first dose of study vaccine or is currently enrolled or plans to participate in another investigational study during the course of this study","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Janssen Vaccines & Prevention B.V. Clinical Trial","affiliation":"Janssen Vaccines & Prevention B.V.","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Synexus Clinical Research US Inc","city":"Birmingham","state":"Alabama","zip":"35209","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"University of Alabama Birmingham","city":"Birmingham","state":"Alabama","zip":"35233","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"Alabama Vaccine Research Clinic at UAB","city":"Birmingham","state":"Alabama","zip":"35294","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"Optimal Research","city":"Huntsville","state":"Alabama","zip":"35802","country":"United States","geoPoint":{"lat":34.7304,"lon":-86.58594}},{"facility":"Synexus Clinical Research US Inc","city":"Glendale","state":"Arizona","zip":"85308","country":"United States","geoPoint":{"lat":33.53865,"lon":-112.18599}},{"facility":"VA Medical Center","city":"Phoenix","state":"Arizona","zip":"85012","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"Central Phoenix Medical Clinic","city":"Phoenix","state":"Arizona","zip":"85020","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"Quality of Life Medical & Research Center, LLC","city":"Tucson","state":"Arizona","zip":"85712","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Synexus Clinical Research US Inc","city":"Tucson","state":"Arizona","zip":"85712","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"University of Arkansas for Medical Sciences","city":"Little Rock","state":"Arkansas","zip":"72202","country":"United States","geoPoint":{"lat":34.74648,"lon":-92.28959}},{"facility":"Central Arkansas Veterans Healthcare System","city":"Little Rock","state":"Arkansas","zip":"72205","country":"United States","geoPoint":{"lat":34.74648,"lon":-92.28959}},{"facility":"Anaheim Clinical Trials, LLC","city":"Anaheim","state":"California","zip":"92801","country":"United States","geoPoint":{"lat":33.83529,"lon":-117.9145}},{"facility":"Ark Clinical Research","city":"Long Beach","state":"California","zip":"90806","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"Anthony Mills Medical, Inc","city":"Los Angeles","state":"California","zip":"90069","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Stanford University Medical Center","city":"Palo Alto","state":"California","zip":"94304","country":"United States","geoPoint":{"lat":37.44188,"lon":-122.14302}},{"facility":"UCSD Antiviral Research Center AVRC","city":"San Diego","state":"California","zip":"92103","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"Wr McCr Llc","city":"San Diego","state":"California","zip":"92108","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"VA Medical Center","city":"San Francisco","state":"California","zip":"94121-1545","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"Childrens Hospital Colorado","city":"Aurora","state":"Colorado","zip":"80045","country":"United States","geoPoint":{"lat":39.72943,"lon":-104.83192}},{"facility":"Rocky Mountain Regional VA Medical Center","city":"Denver","state":"Colorado","zip":"80220","country":"United States","geoPoint":{"lat":39.73915,"lon":-104.9847}},{"facility":"Avail Clinical Research, LLC","city":"DeLand","state":"Florida","zip":"32720","country":"United States","geoPoint":{"lat":29.02832,"lon":-81.30312}},{"facility":"North Florida South Georgia Veteran Health System","city":"Gainesville","state":"Florida","zip":"32608","country":"United States","geoPoint":{"lat":29.65163,"lon":-82.32483}},{"facility":"Velocity Clinical Research, Hallandale Beach","city":"Hallandale","state":"Florida","zip":"33009","country":"United States","geoPoint":{"lat":25.9812,"lon":-80.14838}},{"facility":"Research Centers of America, LLC","city":"Hollywood","state":"Florida","zip":"33024","country":"United States","geoPoint":{"lat":26.0112,"lon":-80.14949}},{"facility":"Suncoast Research Group","city":"Miami","state":"Florida","zip":"33135","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"University of Miami - Miller School of Medicine","city":"Miami","state":"Florida","zip":"33136","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Orlando Immunology Center","city":"Orlando","state":"Florida","zip":"32803","country":"United States","geoPoint":{"lat":28.53834,"lon":-81.37924}},{"facility":"Advent Health Orlando","city":"Orlando","state":"Florida","zip":"32804","country":"United States","geoPoint":{"lat":28.53834,"lon":-81.37924}},{"facility":"Synexus Clinical Research US Inc","city":"Orlando","state":"Florida","zip":"32806","country":"United States","geoPoint":{"lat":28.53834,"lon":-81.37924}},{"facility":"Synexus Clinical Research US Inc","city":"Pinellas Park","state":"Florida","zip":"33781","country":"United States","geoPoint":{"lat":27.8428,"lon":-82.69954}},{"facility":"James A Haley VA Hospital GNS","city":"Tampa","state":"Florida","zip":"33612","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Synexus Clinical Research US Inc","city":"The Villages","state":"Florida","zip":"32162","country":"United States","geoPoint":{"lat":28.93408,"lon":-81.95994}},{"facility":"Emory University of Medicine","city":"Atlanta","state":"Georgia","zip":"30322","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"The Hope Clinic at Emory University","city":"Decatur","state":"Georgia","zip":"30030-1705","country":"United States","geoPoint":{"lat":33.77483,"lon":-84.29631}},{"facility":"Atlanta VA Medical Center","city":"Decatur","state":"Georgia","zip":"30033","country":"United States","geoPoint":{"lat":33.77483,"lon":-84.29631}},{"facility":"Northwestern University","city":"Chicago","state":"Illinois","zip":"60611","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Jesse Brown VAMC Department of Surgery","city":"Chicago","state":"Illinois","zip":"60612","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Rush University Medical Center","city":"Chicago","state":"Illinois","zip":"60612","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"University of IL Chicago","city":"Chicago","state":"Illinois","zip":"60612","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"The University Of Chicago Medicine","city":"Chicago","state":"Illinois","zip":"60637","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Optimal Research","city":"Peoria","state":"Illinois","zip":"61614","country":"United States","geoPoint":{"lat":40.69365,"lon":-89.58899}},{"facility":"Buynak Clinical Research","city":"Valparaiso","state":"Indiana","zip":"46383","country":"United States","geoPoint":{"lat":41.47309,"lon":-87.06114}},{"facility":"Johnson County Clin-Trials","city":"Lenexa","state":"Kansas","zip":"66219","country":"United States","geoPoint":{"lat":38.95362,"lon":-94.73357}},{"facility":"Central Kentucky Research Associates, Inc.","city":"Lexington","state":"Kentucky","zip":"40509","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"University of Kentucky","city":"Lexington","state":"Kentucky","zip":"40536","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"University of Louisville","city":"Louisville","state":"Kentucky","zip":"40202","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}},{"facility":"Benchmark Research","city":"Metairie","state":"Louisiana","zip":"70006","country":"United States","geoPoint":{"lat":29.98409,"lon":-90.15285}},{"facility":"Clinical Trials Management, LLC","city":"Metairie","state":"Louisiana","zip":"70006","country":"United States","geoPoint":{"lat":29.98409,"lon":-90.15285}},{"facility":"New Orleans Adolescent Trials Unit CRS","city":"New Orleans","state":"Louisiana","zip":"70118","country":"United States","geoPoint":{"lat":29.95465,"lon":-90.07507}},{"facility":"Southeast Louisiana Veterans Health Care Center","city":"New Orleans","state":"Louisiana","zip":"70119","country":"United States","geoPoint":{"lat":29.95465,"lon":-90.07507}},{"facility":"Ochsner Clinic Foundation","city":"New Orleans","state":"Louisiana","zip":"70121","country":"United States","geoPoint":{"lat":29.95465,"lon":-90.07507}},{"facility":"Baltimore VA Medical Center","city":"Baltimore","state":"Maryland","zip":"21201","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"Optimal Research","city":"Rockville","state":"Maryland","zip":"20850","country":"United States","geoPoint":{"lat":39.084,"lon":-77.15276}},{"facility":"Meridian Clinical Research, LLC","city":"Rockville","state":"Maryland","zip":"20854","country":"United States","geoPoint":{"lat":39.084,"lon":-77.15276}},{"facility":"Massachusetts General Hospital","city":"Boston","state":"Massachusetts","zip":"02114","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"The Brigham and Women's Hospital, Inc.","city":"Boston","state":"Massachusetts","zip":"02115","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"University of Michigan Neuorsurgery A. Alfred Taubman Health Care Center","city":"Ann Arbor","state":"Michigan","zip":"48109-5000","country":"United States","geoPoint":{"lat":42.27756,"lon":-83.74088}},{"facility":"Henry Ford Health System","city":"Detroit","state":"Michigan","zip":"48202","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"Cherry Street Services, Inc.","city":"Grand Rapids","state":"Michigan","zip":"49503","country":"United States","geoPoint":{"lat":42.96336,"lon":-85.66809}},{"facility":"Abbott Northwestern Hospital Clinic","city":"Minneapolis","state":"Minnesota","zip":"55407","country":"United States","geoPoint":{"lat":44.97997,"lon":-93.26384}},{"facility":"University of Mississippi Medical Center","city":"Jackson","state":"Mississippi","zip":"39216","country":"United States","geoPoint":{"lat":32.29876,"lon":-90.18481}},{"facility":"MediSync Clinical Research","city":"Petal","state":"Mississippi","zip":"39465","country":"United States","geoPoint":{"lat":31.34656,"lon":-89.26006}},{"facility":"The Center For Pharmaceutical Research","city":"Kansas City","state":"Missouri","zip":"64114","country":"United States","geoPoint":{"lat":39.09973,"lon":-94.57857}},{"facility":"Saint Louis University","city":"St Louis","state":"Missouri","zip":"63106","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"Washington University School Of Medicine","city":"St Louis","state":"Missouri","zip":"63110-1035","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"Synexus Clinical Research US Inc","city":"St Louis","state":"Missouri","zip":"63141","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"Clinical Research Center of Nevada","city":"Las Vegas","state":"Nevada","zip":"89106","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Clinical Research Consortium, an AMR company","city":"Las Vegas","state":"Nevada","zip":"89119","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"VA Sierra Nevada Health Care System","city":"Reno","state":"Nevada","zip":"89509","country":"United States","geoPoint":{"lat":39.52963,"lon":-119.8138}},{"facility":"Rutgers Robert Wood Johnson Medical School","city":"New Brunswick","state":"New Jersey","zip":"08903","country":"United States","geoPoint":{"lat":40.48622,"lon":-74.45182}},{"facility":"Saint Michaels Medical Center","city":"Newark","state":"New Jersey","zip":"07102","country":"United States","geoPoint":{"lat":40.73566,"lon":-74.17237}},{"facility":"Raymond G. Murphy VA Medical Center","city":"Albuquerque","state":"New Mexico","zip":"87108","country":"United States","geoPoint":{"lat":35.08449,"lon":-106.65114}},{"facility":"Meridian Clinical Research, LLC","city":"Endwell","state":"New York","zip":"13760","country":"United States","geoPoint":{"lat":42.11285,"lon":-76.02103}},{"facility":"Icahn School of Medicine at Mount Sinai","city":"New York","state":"New York","zip":"10029","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Harlem Hospital Center","city":"New York","state":"New York","zip":"10037","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"New York Blood Center","city":"New York","state":"New York","zip":"10065","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Rochester Clinical Research, Inc","city":"Rochester","state":"New York","zip":"14609","country":"United States","geoPoint":{"lat":43.15478,"lon":-77.61556}},{"facility":"Bronx Veterans Affairs Medical Center","city":"The Bronx","state":"New York","zip":"10468","country":"United States","geoPoint":{"lat":40.84985,"lon":-73.86641}},{"facility":"Tryon Medical Group","city":"Charlotte","state":"North Carolina","zip":"28210","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"Carolina Institute for Clinical Research","city":"Fayetteville","state":"North Carolina","zip":"28304","country":"United States","geoPoint":{"lat":35.05266,"lon":-78.87836}},{"facility":"Durham VAMC","city":"Raleigh","state":"North Carolina","zip":"27610","country":"United States","geoPoint":{"lat":35.7721,"lon":-78.63861}},{"facility":"Wake Research Associates","city":"Raleigh","state":"North Carolina","zip":"27612","country":"United States","geoPoint":{"lat":35.7721,"lon":-78.63861}},{"facility":"Wake Forest Baptist Medical Center","city":"Winston-Salem","state":"North Carolina","zip":"27157","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}},{"facility":"Synexus Clinical Research US Inc","city":"Akron","state":"Ohio","zip":"44311","country":"United States","geoPoint":{"lat":41.08144,"lon":-81.51901}},{"facility":"CTI Clinical Trial and Consulting Services","city":"Cincinnati","state":"Ohio","zip":"45212","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"Synexus Clinical Research US Inc","city":"Cincinnati","state":"Ohio","zip":"45236","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"Velocity Clinical Research","city":"Cincinnati","state":"Ohio","zip":"45242","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"Rapid Medical Research","city":"Cleveland","state":"Ohio","zip":"44122","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"Synexus Clinical Research US Inc","city":"Columbus","state":"Ohio","zip":"43212","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"Corvallis Clinic PC","city":"Corvallis","state":"Oregon","zip":"97330","country":"United States","geoPoint":{"lat":44.56457,"lon":-123.26204}},{"facility":"Clinical Research Institute of Southern Oregon, P.C.","city":"Medford","state":"Oregon","zip":"97504","country":"United States","geoPoint":{"lat":42.32652,"lon":-122.87559}},{"facility":"Oregon Health And Science University","city":"Portland","state":"Oregon","zip":"97239","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"University of Pennsylvania","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"Temple University Hospital","city":"Philadelphia","state":"Pennsylvania","zip":"19140","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"University of Pittsburgh","city":"Pittsburgh","state":"Pennsylvania","zip":"15232","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"Synexus Clinical Research US Inc","city":"Anderson","state":"South Carolina","zip":"29621-2062","country":"United States","geoPoint":{"lat":34.50344,"lon":-82.65013}},{"facility":"VA Medical Center","city":"Columbia","state":"South Carolina","zip":"29201","country":"United States","geoPoint":{"lat":34.00071,"lon":-81.03481}},{"facility":"Coastal Carolina Research Center","city":"Mt. Pleasant","state":"South Carolina","zip":"29464","country":"United States","geoPoint":{"lat":32.79407,"lon":-79.86259}},{"facility":"PMG Research of Charleston, LLC","city":"Mt. Pleasant","state":"South Carolina","zip":"29464","country":"United States","geoPoint":{"lat":32.79407,"lon":-79.86259}},{"facility":"Spartanburg Medical Research","city":"Spartanburg","state":"South Carolina","zip":"29303","country":"United States","geoPoint":{"lat":34.94957,"lon":-81.93205}},{"facility":"St Jude Children's Research Hospital","city":"Memphis","state":"Tennessee","zip":"38105","country":"United States","geoPoint":{"lat":35.14953,"lon":-90.04898}},{"facility":"Vanderbilt University Medical Center","city":"Nashville","state":"Tennessee","zip":"37232","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Benchmark Research","city":"Austin","state":"Texas","zip":"78705","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Optimal Research, LLC","city":"Austin","state":"Texas","zip":"78705","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"AIDS Arms Incorporated Trinity Health and Wellness Center","city":"Dallas","state":"Texas","zip":"75208","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Synexus Clinical Research US Inc","city":"Dallas","state":"Texas","zip":"75234","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Baylor Scott and White Research Institute","city":"Dallas","state":"Texas","zip":"75246","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"North Texas Infectious Diseases Consultants","city":"Dallas","state":"Texas","zip":"75246","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"The University of Texas Health Science Center at Houston","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Texas Center for Drug Development Inc","city":"Houston","state":"Texas","zip":"77081","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Gordon Crofoot, MD","city":"Houston","state":"Texas","zip":"77098","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Clinical Trials of Texas Inc","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Synexus Clinical Research US Inc","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Synexus Clinical Research US Inc","city":"Murray","state":"Utah","zip":"84123","country":"United States","geoPoint":{"lat":40.66689,"lon":-111.88799}},{"facility":"University of Utah","city":"Salt Lake City","state":"Utah","zip":"84132","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"Advanced Clinical Research","city":"West Jordan","state":"Utah","zip":"84088","country":"United States","geoPoint":{"lat":40.60967,"lon":-111.9391}},{"facility":"Kaiser Permanente Washington Health Research Institute","city":"Seattle","state":"Washington","zip":"98101","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"Clínica y Maternidad Suizo Argentina","city":"Buenos Aires","zip":"1118","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"CIPREC","city":"Buenos Aires","zip":"C1119ACN","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"Helios Salud Sa","city":"Buenos Aires","zip":"C1141ACG","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"CEMEDIC","city":"Buenos Aires","zip":"C1440CFD","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"Centro Medico Viamonte SRL","city":"Ciudad Autonoma Buenos Aires","zip":"C1120AAC","country":"Argentina"},{"facility":"Clinical Trials Division-Stamboulian Servicios de Salud","city":"Ciudad Autonoma Buenos Aires","zip":"C1425AWK","country":"Argentina"},{"facility":"Fundacion Huesped","city":"Ciudad Autonoma de Buenos Aire","zip":"C1202ABB","country":"Argentina"},{"facility":"CEMIC Saavedra","city":"Ciudad de Buenos Aires","zip":"1431","country":"Argentina"},{"facility":"Hospital J. M. Ramos Mejía","city":"Ciudad de Buenos Aires","zip":"C1221Adc","country":"Argentina"},{"facility":"Instituto Medico Platense","city":"La Plata","zip":"B1900AVG","country":"Argentina","geoPoint":{"lat":-34.92126,"lon":-57.95442}},{"facility":"Hospital Italiano de La Plata","city":"La Plata","zip":"B1900AXI","country":"Argentina","geoPoint":{"lat":-34.92126,"lon":-57.95442}},{"facility":"DIM Clinica Privada","city":"Ramos Mejía","zip":"B1704ETD","country":"Argentina","geoPoint":{"lat":-34.6551,"lon":-58.55318}},{"facility":"Faculdade de Medicina Barretos FACISB","city":"Barretos","zip":"14785-002","country":"Brazil","geoPoint":{"lat":-20.55722,"lon":-48.56778}},{"facility":"Universidade Federal De Minas Gerais - Hospital das Clínicas","city":"Belo Horizonte","zip":"30130-100","country":"Brazil","geoPoint":{"lat":-19.92083,"lon":-43.93778}},{"facility":"Santa Casa de Misericordia de Belo Horizonte","city":"Belo Horizonte","zip":"30150-221","country":"Brazil","geoPoint":{"lat":-19.92083,"lon":-43.93778}},{"facility":"L2IP Instituto de Pesquisas Clinicas","city":"Brasília","zip":"70200 730","country":"Brazil","geoPoint":{"lat":-15.77972,"lon":-47.92972}},{"facility":"Sociedade Campineira de Educacao e Instrucao Hospital e Maternidade Celso Pierro","city":"Campinas","zip":"13060-904","country":"Brazil","geoPoint":{"lat":-22.90556,"lon":-47.06083}},{"facility":"Fundacao Universidade Federal de Mato Grosso do Sul","city":"Campo Grande","zip":"778606-715","country":"Brazil","geoPoint":{"lat":-20.44278,"lon":-54.64639}},{"facility":"Sociedade Literaria e Caritativa Santo Agostinho Hospital Sao Jose","city":"Criciúma","zip":"88811-508","country":"Brazil","geoPoint":{"lat":-28.6775,"lon":-49.36972}},{"facility":"Oncovida - Centro de Onco-Hematologia de Mato Grosso","city":"Cuiabá","zip":"78043-142","country":"Brazil","geoPoint":{"lat":-15.59611,"lon":-56.09667}},{"facility":"Hospital Nossa Senhora Das Gracas","city":"Curitiba","zip":"80810-040","country":"Brazil","geoPoint":{"lat":-25.42778,"lon":-49.27306}},{"facility":"Centro de Estudos e Pesquisas em Moléstias Infecciosas","city":"Natal","zip":"59025-050","country":"Brazil","geoPoint":{"lat":-5.795,"lon":-35.20944}},{"facility":"Hospital das Clinicas de Porto Alegre","city":"Porto Alegre","zip":"90035-903","country":"Brazil","geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"Hospital Nossa Senhora da Conceicao S A","city":"Porto Alegre","zip":"91350 200","country":"Brazil","geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"Hospital Das Clinicas Da Faculdade De Medicina De RPUSP HCRP","city":"Ribeirão Preto","zip":"14040 900","country":"Brazil","geoPoint":{"lat":-21.1775,"lon":-47.81028}},{"facility":"Ministerio da Saude - Hospital dos Servidores do Estado - RJ","city":"Rio de Janeiro","zip":"20221-160","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Instituto Brasil de Pesquisa Clinica","city":"Rio de Janeiro","zip":"20241-180","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Fundacao Oswaldo Cruz","city":"Rio de Janeiro","zip":"21040-900","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Municipio de Nova Iguacu - Hospital Geral de Nova Iguacu","city":"Rio de Janeiro","zip":"26030-380","country":"Brazil","geoPoint":{"lat":-22.90642,"lon":-43.18223}},{"facility":"Fundacao Bahiana De Infectologia","city":"Salvador","zip":"40110-060","country":"Brazil","geoPoint":{"lat":-12.97563,"lon":-38.49096}},{"facility":"Universidade Municipal de Sao Caetano do Sul","city":"São Caetano do Sul","zip":"09521-160","country":"Brazil","geoPoint":{"lat":-23.62306,"lon":-46.55111}},{"facility":"Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base","city":"São José do Rio Preto","zip":"15090-000","country":"Brazil","geoPoint":{"lat":-20.81972,"lon":-49.37944}},{"facility":"CPQuali Pesquisa Clinica LTDA ME","city":"São Paulo","zip":"01228-000","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Instituto de infectologia Emilio Ribas","city":"São Paulo","zip":"01246-900","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Sociedade Beneficente de Senhoras - Hospital Sírio Libanês","city":"São Paulo","zip":"01308 901","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Real e Benemerita Associacao Portuguesa de Beneficencia","city":"São Paulo","zip":"01323 900","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Centro de Referencia E Treinamento Dst/Aids","city":"São Paulo","zip":"02141-000","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"CEPIC Centro Paulista de Investigacao Clinica e Servicos Medicos","city":"São Paulo","zip":"04266-010","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Hospital Das Clinicas Da Faculdade De Medicina Da USP","city":"São Paulo","zip":"05403 000","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Centro de Estudios Clínicos e Investigación Médica (CeCim)","city":"Santiago","zip":"8331143","country":"Chile","geoPoint":{"lat":-33.45694,"lon":-70.64827}},{"facility":"Facultad de Medicina Universidad de Chile","city":"Santiago","zip":"8380453","country":"Chile","geoPoint":{"lat":-33.45694,"lon":-70.64827}},{"facility":"Hospital Padre Hurtado","city":"Santiago","zip":"8880465","country":"Chile","geoPoint":{"lat":-33.45694,"lon":-70.64827}},{"facility":"Centro de Investigacion del Maule","city":"Talca","zip":"3465586","country":"Chile","geoPoint":{"lat":-35.4232,"lon":-71.64974}},{"facility":"Hospital Dr Hernan Henriquez Aravena","city":"Temuco","zip":"47811-51","country":"Chile","geoPoint":{"lat":-38.73628,"lon":-72.59738}},{"facility":"Centro de Estudios Clinicos V Region Ltda","city":"Viña del Mar","zip":"2520997","country":"Chile","geoPoint":{"lat":-33.02457,"lon":-71.55183}},{"facility":"Clinica de la Costa","city":"Barranquilla","zip":"080001","country":"Colombia","geoPoint":{"lat":10.96854,"lon":-74.78132}},{"facility":"Centro de Reumatologia y Ortopedia","city":"Barranquilla","zip":"080020","country":"Colombia","geoPoint":{"lat":10.96854,"lon":-74.78132}},{"facility":"Hospital Universidad del Norte","city":"Barranquilla","zip":"80020","country":"Colombia","geoPoint":{"lat":10.96854,"lon":-74.78132}},{"facility":"Centro de Atencion e Investigacion Medica S.A. - CAIMED","city":"Bogotá","zip":"00000","country":"Colombia","geoPoint":{"lat":4.60971,"lon":-74.08175}},{"facility":"Medplus Medicina Prepagada S.A.","city":"Bogotá","zip":"110111","country":"Colombia","geoPoint":{"lat":4.60971,"lon":-74.08175}},{"facility":"Solano y Terront Servicios Médicos Ltda.","city":"Bogotá","zip":"110221","country":"Colombia","geoPoint":{"lat":4.60971,"lon":-74.08175}},{"facility":"Centro de Investigaciones Clinicas S A S","city":"Cali","zip":"760001","country":"Colombia","geoPoint":{"lat":3.43054,"lon":-76.5199}},{"facility":"Fundación Valle del Lili","city":"Cali","zip":"760032","country":"Colombia","geoPoint":{"lat":3.43054,"lon":-76.5199}},{"facility":"Fundación Cardiovascular de Colombia - Instituto del Corazón Floridablanca","city":"Floridablanca","zip":"6810002","country":"Colombia","geoPoint":{"lat":7.06222,"lon":-73.08644}},{"facility":"Fundacion Oftalmologica de Santander - FOSCAL","city":"Floridablanca","zip":"681002","country":"Colombia","geoPoint":{"lat":7.06222,"lon":-73.08644}},{"facility":"Programa de Estudio y Control de Enfermedades Tropicales","city":"Medellín","zip":"00000","country":"Colombia","geoPoint":{"lat":6.245,"lon":-75.57151}},{"facility":"Hospital Pablo Tobon Uribe","city":"Medellín","zip":"050034","country":"Colombia","geoPoint":{"lat":6.245,"lon":-75.57151}},{"facility":"Fundacion Centro de Investigacion Clinica CIC","city":"Medellín","country":"Colombia","geoPoint":{"lat":6.245,"lon":-75.57151}},{"facility":"Instituto Nacional de Salud Publica","city":"Cuernavaca","zip":"62100","country":"Mexico","geoPoint":{"lat":18.9261,"lon":-99.23075}},{"facility":"Hospital Civil Fray Antonio Alcalde","city":"Guadalajara","zip":"44280","country":"Mexico","geoPoint":{"lat":20.67738,"lon":-103.34749}},{"facility":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","city":"Mexico City","zip":"14080","country":"Mexico","geoPoint":{"lat":19.42847,"lon":-99.12766}},{"facility":"Unidad de Atención Medica e Investigacion en Salud (UNAMIS)","city":"Mérida","zip":"97000","country":"Mexico","geoPoint":{"lat":20.967,"lon":-89.62318}},{"facility":"Centro Medico Nacional Siglo XXI IMSS","city":"México","zip":"06720","country":"Mexico","geoPoint":{"lat":31.00435,"lon":-108.15213}},{"facility":"CAIMED Investigacion en salud S.A de C.V.","city":"México","zip":"06750","country":"Mexico","geoPoint":{"lat":31.00435,"lon":-108.15213}},{"facility":"Instituto Nacional de Enfermedades Respiratorias","city":"México","zip":"14080","country":"Mexico","geoPoint":{"lat":31.00435,"lon":-108.15213}},{"facility":"Hospital Universitario de Nuevo Leon 'Dr Jose Eleuterio Gonzalez'","city":"Monterrey","zip":"64460","country":"Mexico","geoPoint":{"lat":25.68435,"lon":-100.31721}},{"facility":"Infectolab","city":"Tijuana","zip":"CP 22010","country":"Mexico","geoPoint":{"lat":32.5027,"lon":-117.00371}},{"facility":"Centro de Invetigaciones Medicas","city":"Callao","zip":"0000","country":"Peru","geoPoint":{"lat":-12.05162,"lon":-77.13452}},{"facility":"Hospital Nacional Daniel Alcides Carrion","city":"Callao","zip":"02","country":"Peru","geoPoint":{"lat":-12.05162,"lon":-77.13452}},{"facility":"Centro de Investigaciones Tecnologicas, Biomedica y medio ambientales (CITBM)","city":"Callao","zip":"07066","country":"Peru","geoPoint":{"lat":-12.05162,"lon":-77.13452}},{"facility":"Asociacion Civil Selva Amazonica (ACSA)","city":"Iquitos","zip":"16001","country":"Peru","geoPoint":{"lat":-3.74814,"lon":-73.2529}},{"facility":"Hospital Nacional Edgardo Rebagliati Martins","city":"Lima","zip":"11","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"Hospital Nacional Arzobispo Loayza","city":"Lima","zip":"15082","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"Asociacion Civil Via Libre","city":"Lima","zip":"LIMA 01","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"Instituto de Investigacion Nutricional","city":"Lima","zip":"LIMA12","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"Asociacion Civil Impacta Salud y Educacion- San Miguel CRS","city":"Lima","zip":"LIMA32","country":"Peru","geoPoint":{"lat":-12.04318,"lon":-77.02824}},{"facility":"Asociacion Civil Impacta Salud y Educacion - Barranco","city":"Lima - Barranco","zip":"Barranco 15063","country":"Peru"},{"facility":"Josha Research","city":"Bloemfontein","zip":"9301","country":"South Africa","geoPoint":{"lat":-29.12107,"lon":26.214}},{"facility":"Synexus Helderberg Clinical Research Centre","city":"Cape Town","zip":"7130","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Family Clinical Research Unit FAM-CRU","city":"Cape Town","zip":"7505","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"TASK Central","city":"Cape Town","zip":"7530","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Desmond Tutu HIV Foundation","city":"Cape Town","zip":"7750","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"University of Cape Town IDM/CIDRI Research Site","city":"Cape Town","zip":"7784","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Desmond Tutu Hiv Foundation - University Of Cape Town","city":"Cape Town","zip":"7925","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Masiphumelele Research Centre","city":"Cape Town","zip":"7975","country":"South Africa","geoPoint":{"lat":-33.92584,"lon":18.42322}},{"facility":"Ndlovu Elandsdoorn Site","city":"Dennilton","zip":"0485","country":"South Africa","geoPoint":{"lat":-25.28209,"lon":29.15331}},{"facility":"SA Medical Research Council","city":"Durban","zip":"3660","country":"South Africa","geoPoint":{"lat":-29.8579,"lon":31.0292}},{"facility":"SA Medical Research Council","city":"Durban","zip":"4400","country":"South Africa","geoPoint":{"lat":-29.8579,"lon":31.0292}},{"facility":"CRISMO Bertha Gxowa Research Centre","city":"Johannesburg","zip":"1401","country":"South Africa","geoPoint":{"lat":-26.20227,"lon":28.04363}},{"facility":"Shandukani Research Centre","city":"Johannesburg","zip":"2001","country":"South Africa","geoPoint":{"lat":-26.20227,"lon":28.04363}},{"facility":"The Aurum Institute Klerksdorp Clinical Research Centre","city":"Klerksdorp","zip":"2571","country":"South Africa","geoPoint":{"lat":-26.85213,"lon":26.66672}},{"facility":"Qhakaza Mbokodo Research Centre","city":"KwaZulu-Natal","zip":"4030","country":"South Africa"},{"facility":"South African Medical Research Council Chatsworth Clinical Research Site","city":"KwaZulu-Natal","zip":"4030","country":"South Africa"},{"facility":"Centre for the AIDS Programme of Research in South Africa","city":"KwaZulu-Natal","zip":"4110","country":"South Africa"},{"facility":"Stanza Clinical Research Centre : Mamelodi","city":"Mamelodi East","zip":"0122","country":"South Africa","geoPoint":{"lat":-25.67912,"lon":28.35096}},{"facility":"Mzansi Ethical Research Centre","city":"Middelburg","zip":"1055","country":"South Africa","geoPoint":{"lat":-25.77507,"lon":29.46482}},{"facility":"Nelson Mandela Academic Clinical Research Unit 'NeMACRU'","city":"Mthatha","zip":"5099","country":"South Africa","geoPoint":{"lat":-31.58893,"lon":28.78443}},{"facility":"PHOENIX PHARMA (Pty) Ltd","city":"Port Elizabeth","zip":"6001","country":"South Africa","geoPoint":{"lat":-33.96109,"lon":25.61494}},{"facility":"MeCRU Clinical Research Unit","city":"Pretoria","zip":"0204","country":"South Africa","geoPoint":{"lat":-25.74486,"lon":28.18783}},{"facility":"Synexus Watermeyer","city":"Pretoria","country":"South Africa","geoPoint":{"lat":-25.74486,"lon":28.18783}},{"facility":"The Aurum Institute Rustenburg Clinical Research Site","city":"Rustenburg","zip":"300","country":"South Africa","geoPoint":{"lat":-25.66756,"lon":27.24208}},{"facility":"Setshaba Research Centre","city":"Soshanguve","zip":"152","country":"South Africa","geoPoint":{"lat":-25.47288,"lon":28.09919}},{"facility":"Perinatal HIV Research Unit (PHRU), Kliptown","city":"Soweto","zip":"1809","country":"South Africa","geoPoint":{"lat":-26.26781,"lon":27.85849}},{"facility":"Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital","city":"Soweto","zip":"2013","country":"South Africa","geoPoint":{"lat":-26.26781,"lon":27.85849}},{"facility":"The Aurum Institute: Tembisa - Clinic 4","city":"Tembisa","zip":"1632","country":"South Africa","geoPoint":{"lat":-26.00979,"lon":28.22762}},{"facility":"CAPRISA Vulindlela Clinic","city":"Vulindlela","zip":"4013","country":"South Africa"},{"facility":"University of Witwatersrand - Helen Joseph Hospital - Themba Lethu Hiv Research Centre","city":"Westdene Johannesburg Gauteng","zip":"2092","country":"South Africa"},{"facility":"SATVI, Brewelskloof Hospital","city":"Worcester","zip":"6850","country":"South Africa","geoPoint":{"lat":-33.64651,"lon":19.44852}}]},"referencesModule":{"references":[{"pmid":"39532861","type":"DERIVED","citation":"Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. Nat Commun. 2024 Nov 12;15(1):9785. doi: 10.1038/s41467-024-53727-y."},{"pmid":"39225478","type":"DERIVED","citation":"Janes H, Fisher LH, Kee JJ, Parameswaran L, Goepfert PA, Falsey AR, Ludwig J, Magaret CA, Gilbert PB, Kublin JG, Rouphael N, Sobieszczyk ME, El Sahly HM, Baden LR, Grinsztejn B, Walsh SR, Gray GE, Kotloff KL, Gay CL, Greninger AL, Tapia MD, Hammershaimb EA, Priddy FH, Green JA, Struyf F, Dunkle L, Neuzil KM, Corey L, Huang Y. Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. J Infect Dis. 2024 Dec 16;230(6):1384-1389. doi: 10.1093/infdis/jiae400."},{"pmid":"38467646","type":"DERIVED","citation":"Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun. 2024 Mar 11;15(1):2175. doi: 10.1038/s41467-024-46536-w."},{"pmid":"37385888","type":"DERIVED","citation":"Turley CB, Tables L, Fuller T, Sanders LJ, Scott H, Moodley A, Woodward Davis A, Leav B, Miller J, Schoemaker K, Vandebosch A, Sadoff J, Woo W, Cho I, Dunkle LM, Li S, van der Laan L, Gilbert PB, Follmann D, Jaynes H, Kublin JG, Baden LR, Goepfert P, Kotloff K, Gay CL, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Rouphael N, Luedtke A; COVID-19 Prevention Network CoVPN. Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials. Vaccine. 2023 Jul 25;41(33):4899-4906. doi: 10.1016/j.vaccine.2023.06.066. Epub 2023 Jun 23."},{"pmid":"36357712","type":"DERIVED","citation":"Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, Le Gars M, Van Roey GA, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Hyrien O, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Little SJ, Paiva de Sousa L, Maboa R, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Carpp LN, Follmann D, Gilbert PB, Koup RA, Donis RO; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; and the United States Government (USG)/CoVPN Biostatistics Team. Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial. Nat Microbiol. 2022 Dec;7(12):1996-2010. doi: 10.1038/s41564-022-01262-1. Epub 2022 Nov 10."},{"pmid":"35139271","type":"DERIVED","citation":"Sadoff J, Gray G, Vandebosch A, Cardenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Van Dromme I, Spiessens B, Vingerhoets J, Custers J, Scheper G, Robb ML, Treanor J, Ryser MF, Barouch DH, Swann E, Marovich MA, Neuzil KM, Corey L, Stoddard J, Hardt K, Ruiz-Guinazu J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S. N Engl J Med. 2022 Mar 3;386(9):847-860. doi: 10.1056/NEJMoa2117608. Epub 2022 Feb 9."},{"pmid":"34824596","type":"DERIVED","citation":"Sadoff J, Struyf F, Douoguih M. A plain language summary of how well the single-dose Janssen vaccine works and how safe it is. Future Virol. 2021 Nov;16(11):725-739. doi: 10.2217/fvl-2021-0199. Epub 2021 Nov 1."},{"pmid":"33882225","type":"DERIVED","citation":"Sadoff J, Gray G, Vandebosch A, Cardenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Guinazu J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21."},{"pmid":"33524316","type":"DERIVED","citation":"Williams TC, Burgers WA. SARS-CoV-2 evolution and vaccines: cause for concern? Lancet Respir Med. 2021 Apr;9(4):333-335. doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29. No abstract available."}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"The data sharing policy of the Janssen Pharmaceutical Companies of Johnson \\& Johnson is available at www.janssen.com/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu","url":"https://www.janssen.com/clinical-trials/transparency"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Due to change in the planned analysis, combined data of \"double blind (DB)\" and \"open label (OL)\" phase was collected and analyzed after completion of the double-blind phase. Results of safety outcome measures (OMs) were also collected and analyzed for combined DB and OL phase. Hence, safety data is reported only in adverse event section and not repeated in the OMs section. In all-cause mortality section out of 324 deaths, 1 death was not related to Adverse event.","recruitmentDetails":"A total of 44325 participants were randomized, of which 1 participant was randomized in error due to lack of a signed informed consent form. This participant has not been included in the analysis.","groups":[{"id":"FG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"FG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."},{"id":"FG002","title":"Combined Double-blind and Open-label Phase: All Participants","description":"Participants received a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine or placebo as IM injection on Day 1. At Month 6/unblinding visit, post emergency use authorization (EUA), conditional licensure, or approval for the single dose regimen, participants initially receiving placebo were offered a single dose of Ad26.COV2.S vaccine IM at a dose level of 5\\*10\\^10 vp. As of implementation of protocol amendment 3, participants were allowed to have an outside COVID-19 vaccine. As of implementation of protocol amendment 6, at Year 1 (open label booster vaccination phase), participants who previously received any COVID-19 vaccine (as primary regimen or additional dose) with the Ad26.COV2.S vaccine, and/or an mRNA vaccine or another COVID-19 vaccine authorized for primary vaccination were offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level."}],"periods":[{"title":"DB Phase (Day 1 up to 6 Months)","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"22174"},{"groupId":"FG001","numSubjects":"22150"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Vaccinated","achievements":[{"groupId":"FG000","numSubjects":"21898"},{"groupId":"FG001","numSubjects":"21890"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"21138"},{"groupId":"FG001","numSubjects":"20662"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1036"},{"groupId":"FG001","numSubjects":"1488"},{"groupId":"FG002","numSubjects":"0"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"34"},{"groupId":"FG001","numSubjects":"63"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"271"},{"groupId":"FG001","numSubjects":"333"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"17"},{"groupId":"FG001","numSubjects":"17"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"376"},{"groupId":"FG001","numSubjects":"714"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"61"},{"groupId":"FG001","numSubjects":"98"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Randomized not vaccinated","reasons":[{"groupId":"FG000","numSubjects":"276"},{"groupId":"FG001","numSubjects":"260"},{"groupId":"FG002","numSubjects":"0"}]}]},{"title":"DB + OL Phase (2 Years 6.5 Months)","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","comment":"Only vaccinated participants of combined double blind and open label phase are included in the analysis.","numSubjects":"43788"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"31593"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"12195"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"6"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"324"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"4978"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"342"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"4332"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2211"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"Full Analysis Set (FAS) included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment.","groups":[{"id":"BG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"BG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"21898"},{"groupId":"BG001","value":"21890"},{"groupId":"BG002","value":"43788"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"50.7","spread":"15.08"},{"groupId":"BG001","value":"50.7","spread":"15.04"},{"groupId":"BG002","value":"50.7","spread":"15.06"}]}]}]},{"title":"Sex/Gender, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"9828"},{"groupId":"BG001","value":"9907"},{"groupId":"BG002","value":"19735"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"12067"},{"groupId":"BG001","value":"11979"},{"groupId":"BG002","value":"24046"}]},{"title":"Undifferentiated","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"6"}]},{"title":"Unknown","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"9875"},{"groupId":"BG001","value":"9964"},{"groupId":"BG002","value":"19839"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"11476"},{"groupId":"BG001","value":"11367"},{"groupId":"BG002","value":"22843"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"547"},{"groupId":"BG001","value":"559"},{"groupId":"BG002","value":"1106"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"2083"},{"groupId":"BG001","value":"2060"},{"groupId":"BG002","value":"4143"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"743"},{"groupId":"BG001","value":"686"},{"groupId":"BG002","value":"1429"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"56"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"103"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"4253"},{"groupId":"BG001","value":"4262"},{"groupId":"BG002","value":"8515"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"12858"},{"groupId":"BG001","value":"12843"},{"groupId":"BG002","value":"25701"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"1207"},{"groupId":"BG001","value":"1248"},{"groupId":"BG002","value":"2455"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"698"},{"groupId":"BG001","value":"744"},{"groupId":"BG002","value":"1442"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"ARGENTINA","categories":[{"measurements":[{"groupId":"BG000","value":"1498"},{"groupId":"BG001","value":"1498"},{"groupId":"BG002","value":"2996"}]}]},{"title":"BRAZIL","categories":[{"measurements":[{"groupId":"BG000","value":"3644"},{"groupId":"BG001","value":"3635"},{"groupId":"BG002","value":"7279"}]}]},{"title":"CHILE","categories":[{"measurements":[{"groupId":"BG000","value":"563"},{"groupId":"BG001","value":"570"},{"groupId":"BG002","value":"1133"}]}]},{"title":"COLOMBIA","categories":[{"measurements":[{"groupId":"BG000","value":"2125"},{"groupId":"BG001","value":"2123"},{"groupId":"BG002","value":"4248"}]}]},{"title":"MEXICO","categories":[{"measurements":[{"groupId":"BG000","value":"238"},{"groupId":"BG001","value":"241"},{"groupId":"BG002","value":"479"}]}]},{"title":"PERU","categories":[{"measurements":[{"groupId":"BG000","value":"886"},{"groupId":"BG001","value":"885"},{"groupId":"BG002","value":"1771"}]}]},{"title":"SOUTH AFRICA","categories":[{"measurements":[{"groupId":"BG000","value":"3287"},{"groupId":"BG001","value":"3289"},{"groupId":"BG002","value":"6576"}]}]},{"title":"UNITED STATES","categories":[{"measurements":[{"groupId":"BG000","value":"9657"},{"groupId":"BG001","value":"9649"},{"groupId":"BG002","value":"19306"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical Coronavirus Disease (COVID-19) With Seronegative Status With Onset at Least 14 Days After Double-blind Vaccination on Day 1 (Day 15): Double-blind Phase","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positive reverse transcription/polymerase chain reaction (RT-PCR) or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, oxygen saturation (SpO2) \\<= 93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"Per-protocol Efficacy (PP) set: participants of the FAS (all randomized participants with double-blind study vaccine administration, regardless of protocol deviations and serostatus at enrollment) who received double-blind study vaccine and who were seronegative at the time of vaccination and who had no other major protocol deviations to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From 14 days after double-blind vaccination on Day 1 (Day 15) up to Month 6","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19400"},{"groupId":"OG001","value":"19398"}]}],"classes":[{"title":"Age: 18-59 years","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12665"},{"groupId":"OG001","value":"12674"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"381"},{"groupId":"OG001","value":"847"}]}]},{"title":"Age: Greater than or equal to (>=) 60 years","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6735"},{"groupId":"OG001","value":"6724"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"103"},{"groupId":"OG001","value":"220"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 With Seronegative Status With Onset at Least 28 Days After Double-blind Vaccination on Day 1 (Day 29): Double-blind Phase","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>=20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats/minute and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute, SpO2 less than or equal to (\\<=) 93 percent (%) on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the Intensive Care Unit (ICU), death defined as per Food and Drug Administration (FDA) guidance.","populationDescription":"PP set included participants of the Full Analysis Set (FAS) who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From 28 days after double-blind vaccination on Day 1 (Day 29) up to Month 6","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"title":"Age: 18-59 years","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12489"},{"groupId":"OG001","value":"12350"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"340"},{"groupId":"OG001","value":"716"}]}]},{"title":"Age: >=60 years","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6624"},{"groupId":"OG001","value":"6574"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"93"},{"groupId":"OG001","value":"167"}]}]},{"title":"All participants","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"433"},{"groupId":"OG001","value":"883"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Solicited Local Adverse Events (AEs) Up to 7 Days After Booster Vaccination (Open-label Booster Vaccination Phase)","description":"Participants who received the booster dose were asked to note in the e-Diary occurrences of injection site pain/tenderness, erythema, and swelling at the study vaccine injection site daily for 7 days post-booster vaccination (day of vaccination and the subsequent 7 days).","populationDescription":"Full analysis booster set included all randomized participants with a documented study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment, who received the Ad26.COV2.S booster vaccination at the booster visit.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to Day 372 (7 Days after booster vaccination on Day 365 [Year 1])","groups":[{"id":"OG000","title":"OL Phase: Ad26.COV2.S 5*10^10 vp + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants received a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine or placebo as IM injection on Day 1. At Month 6/unblinding visit, participants initially receiving placebo were offered a single dose of Ad26.COV2.S vaccine IM injection at a dose level of 5\\*10\\^10 vp. At Year 1 (booster visit), participants who previously received any COVID-19 vaccine (as primary regimen or additional dose) were offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level as booster vaccination."},{"id":"OG001","title":"Open Label Phase: mRNA 2 Dose Schedule + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S as IM injection on Day 1 in the double blind phase and received 2 doses of mRNA vaccination outside of the trial further received an Ad26.COV2.S booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination."},{"id":"OG002","title":"OL Phase: Non-mRNA Any Schedule +Ad26.COV2.S vp Booster OR mRNA Other Schedule +Ad26.COV2.S Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S IM injection on Day 1 in double blind phase and received non-mRNA vaccination outside of the trial or only 1 dose of mRNA vaccination or more than 2 doses of mRNA vaccination further received an Ad26.COV2 booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"22213"},{"groupId":"OG001","value":"613"},{"groupId":"OG002","value":"943"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3758"},{"groupId":"OG001","value":"135"},{"groupId":"OG002","value":"204"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Solicited Systemic AEs Up to 7 Days After Booster Vaccination (Open-label Booster Vaccination Phase)","description":"Participants recorded the temperature in the e-Diary in the evening of the day of vaccination, and then daily for the next 7 days approximately at the same time each day. If more than 1 measurement was made on any given day, the highest temperature of that day was recorded in the e-Diary. Fever was defined as endogenous elevation of body temperature \\>= 38.0 degree Celsius or \\>=100.4-degree Fahrenheit, as recorded in at least 1 measurement. Participants also noted the signs and symptoms in the e-Diary on a daily basis for 7 days post-booster vaccination (day of vaccination and the subsequent 7 days), if feasible, for the following events: fatigue, headache, nausea, myalgia.","populationDescription":"Full analysis booster set included all randomized participants with a documented study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment, who received the Ad26.COV2.S booster vaccination at the booster visit.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to Day 372 (7 Days after booster vaccination on Day 365 [Year 1])","groups":[{"id":"OG000","title":"OL Phase: Ad26.COV2.S 5*10^10 vp + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants received a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine or placebo as IM injection on Day 1. At Month 6/unblinding visit, participants initially receiving placebo were offered a single dose of Ad26.COV2.S vaccine IM injection at a dose level of 5\\*10\\^10 vp. At Year 1 (booster visit), participants who previously received any COVID-19 vaccine (as primary regimen or additional dose) were offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level as booster vaccination."},{"id":"OG001","title":"Open Label Phase: mRNA 2 Dose Schedule + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S as IM injection on Day 1 in the double blind phase and received 2 doses of mRNA vaccination outside of the trial further received an Ad26.COV2.S booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination."},{"id":"OG002","title":"OL Phase: Non-mRNA Any Schedule +Ad26.COV2.S vp Booster OR mRNA Other Schedule +Ad26.COV2.S Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S IM injection on Day 1 in double blind phase and received non-mRNA vaccination outside of the trial or only 1 dose of mRNA vaccination or more than 2 doses of mRNA vaccination further received an Ad26.COV2 booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"22213"},{"groupId":"OG001","value":"613"},{"groupId":"OG002","value":"943"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3559"},{"groupId":"OG001","value":"145"},{"groupId":"OG002","value":"198"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Unsolicited AEs Up to 28 Days After Booster Vaccination (Open-label Booster Vaccination Phase)","description":"Unsolicited AEs were all AEs for which the participant is not specifically questioned in the participant diary.","populationDescription":"Full analysis booster set included all randomized participants with a documented study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment, who received the Ad26.COV2.S booster vaccination at the booster visit.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to Day 393 (28 Days after booster vaccination on Day 365 [Year 1])","groups":[{"id":"OG000","title":"OL Phase: Ad26.COV2.S 5*10^10 vp + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants received a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine or placebo as IM injection on Day 1. At Month 6/unblinding visit, participants initially receiving placebo were offered a single dose of Ad26.COV2.S vaccine IM injection at a dose level of 5\\*10\\^10 vp. At Year 1 (booster visit), participants who previously received any COVID-19 vaccine (as primary regimen or additional dose) were offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level as booster vaccination."},{"id":"OG001","title":"Open Label Phase: mRNA 2 Dose Schedule + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S as IM injection on Day 1 in the double blind phase and received 2 doses of mRNA vaccination outside of the trial further received an Ad26.COV2.S booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination."},{"id":"OG002","title":"OL Phase: Non-mRNA Any Schedule +Ad26.COV2.S vp Booster OR mRNA Other Schedule +Ad26.COV2.S Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S IM injection on Day 1 in double blind phase and received non-mRNA vaccination outside of the trial or only 1 dose of mRNA vaccination or more than 2 doses of mRNA vaccination further received an Ad26.COV2 booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"22213"},{"groupId":"OG001","value":"613"},{"groupId":"OG002","value":"943"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2133"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"95"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Severe/Critical COVID-19 With Seronegative Status With Onset at Least 14 Days After Double-blind Vaccination on Day 1 (Day 15): Double-blind Phase","description":"Molecularly confirmed severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance. Seronegative is defined as N-serology seronegative at the time of boosting or at the Year 1 visit if not boosted.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From 14 days after double-blind vaccination on Day 1 (Day 15) up to Month 6","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19400"},{"groupId":"OG001","value":"19398"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"205"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Severe/Critical COVID-19 With Seronegative Status With Onset at Least 28 Days After Double-blind Vaccination on Day 1 (Day 29): Double-blind Phase","description":"Severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 in PP set were excluded. Here, N (Overall number of participants analyzed) signifies participants evaluable for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From 28 days after double-blind vaccination on Day 1 (Day 29) up to Month 6","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"176"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Their Serostatus (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"FAS included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"1 day after double-blind vaccination on Day 1 (Day 2)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21898"},{"groupId":"OG001","value":"21890"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"575"},{"groupId":"OG001","value":"1189"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Their Serostatus (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine, regardless of their serostatus at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. This excludes participants who had a COVID-19 case with an onset before Day 15.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"14 days after double-blind vaccination on Day 1 (Day 15)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21537"},{"groupId":"OG001","value":"21467"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"487"},{"groupId":"OG001","value":"1079"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Moderate to Severe/Critical COVID-19 Regardless of Their Serostatus (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine, regardless of their serostatus at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. This excludes participants who had a COVID-19 case with an onset before Day 29.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 days after double-blind vaccination on Day 1 (Day 29)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21244"},{"groupId":"OG001","value":"20978"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"436"},{"groupId":"OG001","value":"895"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of COVID-19 Requiring Medical Intervention (Double Blind Phase)","description":"Number of participants with first occurrence of COVID-19 requiring medical intervention (such as a composite endpoint of hospitalization, ICU admission, mechanical ventilation, and extracorporeal membrane oxygenation \\[ECMO\\], linked to objective measures such as decreased oxygenation, X-ray or computed tomography \\[CT\\] findings) or linked to any molecularly confirmed, COVID-19 at least 14 days post vaccination were reported.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"14 days after double-blind vaccination on Day 1 (Day 15)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19400"},{"groupId":"OG001","value":"19398"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"74"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of COVID-19 Requiring Medical Intervention (Double Blind Phase)","description":"Number of participants with first occurrence of COVID-19 requiring medical intervention (such as a composite endpoint of hospitalization, ICU admission, mechanical ventilation, and ECMO, linked to objective measures such as decreased oxygenation, X-ray or CT findings) or linked to any molecularly confirmed, COVID-19 at least 28 days post vaccination were reported.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"64"}]}]}]},{"type":"SECONDARY","title":"Area Under the Curve (AUC) of SARS-CoV-2 Viral Load as Assessed by Quantitative Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) in Participants With Molecularly Confirmed, Moderate to Severe/Critical COVID-19 (Double Blind Phase)","description":"AUC of SARS-CoV-2 Viral Load was assessed in confirmed COVID-19 cases using RT-PCR. Nasal swabs were used to detect and/or quantify SARS-CoV-2.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded. Here N (Overall number of participants analyzed) signifies participants evaluable for this OM.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Error","unitOfMeasure":"Log10 copies*day per milliliter","timeFrame":"From Day 15 to end of the COVID-19 episode (Day 189)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"483"},{"groupId":"OG001","value":"1041"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"823.7","spread":"33.668"},{"groupId":"OG001","value":"921.47","spread":"25.706"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Mild COVID-19 (Double Blind Phase","description":"Molecularly confirmed mild Covid-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: fever (\\>=38°C or \\>=100.4°F), sore throat, malaise (loss of appetite, generally unwell, fatigue, physical weakness), headache, muscle pain (myalgia), gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, new or changing olfactory or taste disorders, red or bruised looking feet or toes, or shaking chills or rigors.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"14 Days after double-blind vaccination on Day1 (Day 15)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19400"},{"groupId":"OG001","value":"19398"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"15"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed Mild COVID-19 (Double Blind Phase)","description":"Molecularly confirmed mild Covid-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample and one of the following signs and symptoms: fever (\\>=38°C or \\>=100.4°F), sore throat, malaise (loss of appetite, generally unwell, fatigue, physical weakness), headache, muscle pain (myalgia), gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, new or changing olfactory or taste disorders, red or bruised looking feet or toes, or shaking chills or rigors.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"12"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US Food and Drug Administration (FDA) Harmonized Case Definition (Double Blind Phase)","description":"Molecularly confirmed COVID-19 was defined as a positive SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample; and COVID-19 symptoms consistent with those defined by the US FDA harmonized case definition at the time of finalization of the study protocol: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, diarrhea.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"14 Days after double-blind vaccination on Day 1 (Day 15)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19400"},{"groupId":"OG001","value":"19398"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"492"},{"groupId":"OG001","value":"1067"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US Food and Drug Administration (FDA) Harmonized Case Definition (Double Blind Phase)","description":"Molecularly confirmed COVID-19 was defined as a positive SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample; and COVID-19 symptoms consistent with those defined by the US FDA harmonized case definition at the time of finalization of the study protocol: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, diarrhea.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"441"},{"groupId":"OG001","value":"884"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Burden of Disease (BOD) Based on First Occurrence of Molecularly Confirmed Symptomatic COVID-19 (Double Blind Phase)","description":"BOD is a weighted version of the mild, moderate, and severe/critical vaccine efficacies and was evaluated based on the first occurrence of molecularly confirmed COVID-19, including mild, moderate or severe/critical COVID-19 case.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 14 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"14 Days after double-blind vaccination on Day 1 (Day 15)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19400"},{"groupId":"OG001","value":"19398"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"495"},{"groupId":"OG001","value":"1082"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With BOD Based on First Occurrence of Molecularly Confirmed Symptomatic COVID-19 (Double Blind Phase)","description":"BOD is a weighted version of the mild, moderate, and severe/critical vaccine efficacies and was evaluated based on the first occurrence of molecularly confirmed COVID-19, including mild, moderate or severe/critical COVID-19 case.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a positive PCR test between Day 1 and Day 28 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 Days after double-blind vaccination on Day 1 (Day 29)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"443"},{"groupId":"OG001","value":"895"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With SARS-CoV-2 Seroconversion Based on Antibodies to N Protein Using ELISA and/or SARS-CoV-2 Immunoglobulin Assay (Double Blind Phase)","description":"Number of participants with SARS-CoV-2 seroconversion based on antibodies to nucleocapsid (N) protein using enzyme-linked immunosorbent assay (ELISA) and/or SARS-CoV- 2 immunoglobulin assay that is dependent on the SARS-CoV-2 N protein was reported.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Participants who had a COVID-19 case with an onset or discontinued before day 29 in PP set were excluded.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 29 until end of double-blind phase at Month 6","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"550"},{"groupId":"OG001","value":"724"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Asymptomatic Infection Detected by RT-PCR at the Time of the Month 6/Unblinding Visit (Double Blind Phase)","description":"Number of participants with asymptomatic infection detected by RT-PCR at the time of the Month 6/unblinding visit were reported.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Month 6","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"12"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of SARS-CoV-2 Infection (Serologically and/or Molecularly Confirmed) (Double Blind Phase)","description":"Number of participants with first occurrence of SARS-CoV-2 infection (serologically and/or molecularly confirmed) were reported.","populationDescription":"PP set included participants of the FAS who received double-blind study vaccine and who were seronegative at the time of double-blind vaccination and who had no other major protocol deviations that were judged to possibly impact the efficacy of the vaccine. Here \"N\" signifies the excluded participants who had a COVID-19 case with an onset or discontinued before Day 29.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"28 days after double-blind vaccination on Day 1 (Day 29)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"19113"},{"groupId":"OG001","value":"18924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1038"},{"groupId":"OG001","value":"1699"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With First Occurrence of Molecularly Confirmed, Moderate to Severe/Critical COVID-19 for Seronegative Participants (Double Blind Phase)","description":"Molecularly confirmed moderate to severe/critical COVID-19 was defined as a SARS-CoV-2 positive RT-PCR or molecular test result from any available respiratory tract sample (example, nasal swab sample, sputum sample, throat swab sample, saliva sample) or other sample. Moderate included one sign or symptom such as respiratory rate \\>= 20 breaths per minute and symptoms such as shortness of breath or two signs or symptoms such as heart rate \\>= 90 beats per minute (beats/minute) and symptoms such as cough from a list of signs and symptoms and severe/critical included one of the following signs and symptoms: respiratory rate \\>=30 breaths/minute, heart rate \\>=125 beats/minute,SpO2 \\<=93% on room air at sea level respiratory failure, evidence of shock, significant acute renal, hepatic, or neurologic dysfunction, admission to the ICU, death defined as per FDA guidance. Seronegative is defined as N-serology seronegative at the time of boosting or at the Year 1 visit if not boosted.","populationDescription":"FAS included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"1 day after double-blind vaccination on Day 1 (Day 2)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21898"},{"groupId":"OG001","value":"21890"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"575"},{"groupId":"OG001","value":"1189"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Serious Adverse Events (SAEs) (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. SAE is any untoward medical occurrence that at any dose may result in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product.","populationDescription":"FAS included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Baseline (Day 1) up to 35 weeks","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21894"},{"groupId":"OG001","value":"21882"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"235"},{"groupId":"OG001","value":"358"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Adverse Events of Special Interest (AESI) (Double Blind Phase)","description":"Number of participants with AESIs were reported. AESIs are significant AEs that are judged to be of special interest because of clinical importance, known or suspected class effects, or based on nonclinical signals. Thrombosis with Thrombocytopenia Syndrome (TTS), a syndrome characterized by a combination of both a thrombotic event and thrombocytopenia, is considered to be an AESI in this study. A suspected TTS case is defined as: Thrombotic events: suspected deep vessel venous or arterial thrombotic events; Thrombocytopenia, defined as platelet count below 150,000/micro liter.","populationDescription":"FAS included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure (OM).","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Baseline (Day 1) up to 35 weeks","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21894"},{"groupId":"OG001","value":"21882"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Medically-Attended Adverse Events (MAAEs) (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason.","populationDescription":"FAS included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to 6 months after double-blind vaccination on Day 1 (up to 6 months)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21894"},{"groupId":"OG001","value":"21882"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1672"},{"groupId":"OG001","value":"1885"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With MAAEs Leading to Study Discontinuation (Double Blind Phase)","description":"MAAEs were defined as AEs with medically-attended visits including hospital, emergency room, urgent care clinic, or other visits to or from medical personnel for any reason. Routine study visits were not considered medically-attended visits. New onset of chronic diseases was collected as part of the MAAEs.","populationDescription":"FAS included all randomized participants with a documented double-blind study vaccine administration, regardless of the occurrence of protocol deviations and serostatus at enrollment. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to 35 weeks","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21894"},{"groupId":"OG001","value":"21882"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Solicited Local Adverse Events (AEs) During 7 Days Following Vaccination (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. Participants who were enrolled in safety subset were asked to note in the e-Diary occurrences of injection site pain/tenderness, erythema, and swelling at the study vaccine injection site daily for 7 days post-vaccination (day of vaccination and the subsequent 7 days).","populationDescription":"Safety population is a subset of FAS for the analysis of solicited local adverse event. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to Day 8 (7 Days after double-blind vaccination on Day 1)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3356"},{"groupId":"OG001","value":"3379"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1839"},{"groupId":"OG001","value":"684"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Solicited Systemic AEs During 7 Days Following Vaccination (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with pharmaceutical/biological agent under study. Participants who were enrolled in safety subset were instructed on how to record daily temperature using a thermometer provided for home use. Participants recorded the temperature in the e-Diary in the evening of the day of vaccination, and then daily for the next 7 days approximately at the same time each day. If more than 1 measurement was made on any given day, the highest temperature of that day was recorded in the e-Diary. Fever was defined as endogenous elevation of body temperature \\>= 38.0 degree Celsius or \\>=100.4-degree Fahrenheit, as recorded in at least 1 measurement. Participants also noted the signs and symptoms in the e-Diary on a daily basis for 7 days post vaccination (day of vaccination and the subsequent 7 days), for the following events: fatigue, headache, nausea, myalgia.","populationDescription":"Safety population is a subset of FAS for the analysis of solicited systemic adverse event. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to Day 8 (7 Days after double-blind vaccination on Day 1)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3356"},{"groupId":"OG001","value":"3379"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2021"},{"groupId":"OG001","value":"1307"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Unsolicited AEs During 28 Days Post-vaccination (Double Blind Phase)","description":"An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. Unsolicited AEs were all AEs for which the participant is not specifically questioned in the participant diary.","populationDescription":"Safety population is a subset of FAS for the analysis of unsolicited adverse event. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to Day 29 (28 Days after double-blind vaccination on Day 1)","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3356"},{"groupId":"OG001","value":"3379"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"456"},{"groupId":"OG001","value":"422"}]}]}]},{"type":"SECONDARY","title":"Binding Antibodies to SARS-CoV-2 S Protein Assessed by ELISA (Double Blind Phase)","description":"Binding antibodies to SARS-CoV-2 S protein as assessed by enzyme-linked immunosorbent assay (ELISA) to measure humoral immune response was reported. The lower limit of quantification (LLOQ) and upper limit of quantification (ULOQ) were 50.3 EU/mL and 58,158.10 EU/mL, respectively. A sample was considered positive if the value was strictly greater than the LLOQ (\\>LLOQ).","populationDescription":"PPI set included all randomized and vaccinated participants, including those who were part of the immunogenicity subset and for whom immunogenicity data were available, excluding participants with major protocol deviations expected to impact the immunogenicity outcomes. Here N (Overall number of participants analyzed) signifies participants evaluated for this outcome measure and 'n' (number analyzed) signifies number of participants evaluable at specified time points.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"ELISA units per milliliter (EU/mL)","timeFrame":"Baseline (Day 1), Day 29, and Day 71","groups":[{"id":"OG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1."},{"id":"OG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"193"},{"groupId":"OG001","value":"167"}]}],"classes":[{"title":"Baseline (Day 1)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"193"},{"groupId":"OG001","value":"167"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Here NA signifies that the sample was not positive as Geometric mean, and 95% confidence interval value were less than LLOQ i.e., 50.3 EU/mL."},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Here NA signifies that the sample was not positive as Geometric mean, and 95% confidence interval value were less than LLOQ i.e., 50.3 EU/mL."}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"177"},{"groupId":"OG001","value":"154"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"336","lowerLimit":"284","upperLimit":"398"},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Here NA signifies that the sample was not positive as Geometric mean, and 95% confidence interval value were less than LLOQ i.e., 50.3 EU/mL."}]}]},{"title":"Day 71","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"164"},{"groupId":"OG001","value":"138"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"526","lowerLimit":"437","upperLimit":"633"},{"groupId":"OG001","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"Here NA signifies that the sample was not positive as Geometric mean, and 95% confidence interval value were less than LLOQ i.e., 50.3 EU/mL."}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Antibody Titers to Ad26.COV2.S (Booster Phase)","description":"Number of participants with antibody titers to Ad26.COV2.S to measure immune response were reported.","populationDescription":"PPI booster analysis set included all participants who received an Ad26.COV2.S booster dose (Year 1(Week 52)/Booster Visit) and who had been selected for inclusion in homologous or heterologous booster subset as of protocol amendment 6. This OM was planned to be analyzed based on homologous and heterologous booster groups. Here, \"0\" participants in \"overall number of participants analyzed\" field indicated that data for this OM was not collected and analyzed due to change in planned analysis.","reportingStatus":"POSTED","timeFrame":"28 days after booster vaccination on Day 365 (up to Day 393)","groups":[{"id":"OG000","title":"Homologous Booster Group (2 Doses of Ad26.COV2.S 5*10^10 vp)","description":"As per protocol amendment 6, in homologous booster group participants received 2 doses of Ad26.COV2.S 5\\*10\\^10 vp (Ad26.COV2.S booster vaccination following an early or late first Ad26.COV2.S vaccination) as early booster group in which duration between the 2 doses of Ad26.COV2.S 5\\*10\\^10 vp was less than (\\<) 6 months or late booster group in which duration between the 2 doses of Ad26.COV2.S. was \\>=6 months."},{"id":"OG001","title":"Heterologous Booster Group: Placebo + 2 Doses of mRNA Vaccine + Ad26.COV2.S 5*10^10 vp","description":"As per protocol amendment 6, participants who received placebo at Day 1 during the double blind phase and had received primary vaccination with an mRNA vaccine outside of the study further received Ad26.COV2.S 5\\*10\\^10 vp booster vaccination at Year 1 booster visit."},{"id":"OG002","title":"Heterologous Booster Group: Ad26.COV2.S 5*10^10 vp Booster After Any Other Schedule","description":"As per protocol amendment 6, participants who received placebo on Day 1 in the double-blind phase and had received primary vaccination with any other COVID-19 vaccination schedule outside of the study that is other adenoviral vector, further received an Ad26.COV2.S 5\\*10\\^10 vp booster vaccination at Year 1 booster vaccination visit."},{"id":"OG003","title":"Heterologous Booster Group: Inactivated Vaccine + Ad26.COV2.S 5*10^10 vp","description":"As per protocol amendment 6, participants who received placebo in the double-blind phase and had received primary vaccination with inactivated vaccine further received an Ad26.COV2.S 5\\*10\\^10 vp booster vaccination at Year 1 booster vaccination visit."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"type":"SECONDARY","title":"Number of Participants With Binding Antibodies to SARS- CoV-2S Protein as Measured by ELISA (Booster Phase)","description":"Number of participants with binding antibodies to SARS- CoV-2S protein as measured by ELISA was reported.","populationDescription":"Per protocol booster immunogenicity analysis set included all participants who received an Ad26.COV2.S booster dose (Year 1 \\[Week 52\\]/Booster Visit) and who had been selected for inclusion in the homologous or heterologous booster subset as of protocol amendment 6. Here, 'N' (number of participants analyzed) signifies participants evaluable for this outcome measure. As planned, this outcome measure was analyzed based on homologous and heterologous booster groups.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"29 days after booster vaccination on Day 365 (Day 394)","groups":[{"id":"OG000","title":"Homologous Booster Group (2 Doses of Ad26.COV2.S 5*10^10 vp)","description":"As per protocol amendment 6, in homologous booster group participants received 2 doses of Ad26.COV2.S 5\\*10\\^10 vp (Ad26.COV2.S booster vaccination following an early or late first Ad26.COV2.S vaccination) as early booster group in which duration between the 2 doses of Ad26.COV2.S 5\\*10\\^10 vp was less than (\\<) 6 months or late booster group in which duration between the 2 doses of Ad26.COV2.S. was \\>=6 months."},{"id":"OG001","title":"Heterologous Booster Group: Placebo + 2 Doses of mRNA Vaccine + Ad26.COV2.S 5*10^10 vp","description":"As per protocol amendment 6, participants who received placebo at Day 1 during the double blind phase and had received primary vaccination with an mRNA vaccine outside of the study further received Ad26.COV2.S 5\\*10\\^10 vp booster vaccination at Year 1 booster visit."},{"id":"OG002","title":"Heterologous Booster Group: Ad26.COV2.S 5*10^10 vp Booster After Any Other Schedule","description":"As per protocol amendment 6, participants who received placebo on Day 1 in the double-blind phase and had received primary vaccination with any other COVID-19 vaccination schedule outside of the study that is other adenoviral vector, further received an Ad26.COV2.S 5\\*10\\^10 vp booster vaccination at Year 1 booster vaccination visit."},{"id":"OG003","title":"Heterologous Booster Group: Inactivated Vaccine + Ad26.COV2.S 5*10^10 vp","description":"As per protocol amendment 6, participants who received placebo in the double-blind phase and had received primary vaccination with inactivated vaccine further received an Ad26.COV2.S 5\\*10\\^10 vp booster vaccination at Year 1 booster vaccination visit."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"11"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"3"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"2","timeFrame":"DB phase: All-cause mortality and SAEs: Baseline (Day 1) up to 35 weeks; Other AEs: Day 1 till 28 days after first vaccination; All participants Arm: all-cause mortality and SAEs: Day 1 up to end of study (up to 2 years 6.5 months); Booster treatment groups: Other AEs: from Day 1 till 28 days after booster vaccination on Day 365 (up to Day 393). Solicited AEs: 7 days after first/booster vaccination","description":"Per change in planned analysis: data for DB \\& OL phase (booster arms) was collected \\& reported in 'All participants' arms for all-cause mortality and SAEs. Thus, at risk=0 for booster arms. Other AEs: per plan, Safety subset (subset of FAS) was used and hence at risk=0 for 'All participants' arm as this arm had all treated participants. AEs in DB arms were coded with MedDRA Version 24.0. Same AEs might differ in names in both phases due to coding with different MedDRA versions.","eventGroups":[{"id":"EG000","title":"Double-blind Phase: Ad26.COV2.S 5*10^10 vp","description":"Participants received intramuscular (IM) injection of Ad26.COV2.S at a dose level of 5\\*10\\^10 virus particles (vp) as single dose vaccine on Day 1.","deathsNumAffected":36,"deathsNumAtRisk":21898,"seriousNumAffected":235,"seriousNumAtRisk":21898,"otherNumAffected":2451,"otherNumAtRisk":3356},{"id":"EG001","title":"Double-blind Phase: Placebo","description":"Participants received IM injection of placebo matching to Ad26.COV2.S on Day 1.","deathsNumAffected":64,"deathsNumAtRisk":21890,"seriousNumAffected":358,"seriousNumAtRisk":21890,"otherNumAffected":1653,"otherNumAtRisk":3380},{"id":"EG002","title":"Combined Double-blind and Open-label Phase: All Participants","description":"Participants received a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine or placebo as IM injection on Day 1. At Month 6/unblinding visit, post emergency use authorization (EUA), conditional licensure, or approval for the single dose regimen, participants initially receiving placebo were offered a single dose of Ad26.COV2.S vaccine IM at a dose level of 5\\*10\\^10 vp. As of implementation of protocol amendment 3, participants were allowed to have an outside COVID-19 vaccine. As of implementation of protocol amendment 6, at Year 1 (open label booster vaccination phase), participants who previously received any COVID-19 vaccine (as primary regimen or additional dose) with the Ad26.COV2.S vaccine, and/or an mRNA vaccine or another COVID-19 vaccine authorized for primary vaccination were offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level.","deathsNumAffected":324,"deathsNumAtRisk":43788,"seriousNumAffected":2758,"seriousNumAtRisk":43788,"otherNumAffected":0,"otherNumAtRisk":0},{"id":"EG003","title":"OL Phase: Ad26.COV2.S 5*10^10 vp + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants received a single dose of Ad26.COV2.S 5\\*10\\^10 vp vaccine or placebo as IM injection on Day 1. At Month 6/unblinding visit, participants initially receiving placebo were offered a single dose of Ad26.COV2.S vaccine IM injection at a dose level of 5\\*10\\^10 vp. At Year 1 (booster visit), participants who previously received any COVID-19 vaccine (as primary regimen or additional dose) were offered a single booster dose of Ad26.COV2.S at the 5\\*10\\^10 vp dose level as booster vaccination.","deathsNumAffected":0,"deathsNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"otherNumAffected":6048,"otherNumAtRisk":22213},{"id":"EG004","title":"Open Label Phase: mRNA 2 Dose Schedule + Ad26.COV2.S 5*10^10 vp Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S as IM injection on Day 1 in the double blind phase and received 2 doses of mRNA vaccination outside of the trial further received an Ad26.COV2.S booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination.","deathsNumAffected":0,"deathsNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"otherNumAffected":190,"otherNumAtRisk":613},{"id":"EG005","title":"OL Phase: Non-mRNA Any Schedule +Ad26.COV2.S vp Booster OR mRNA Other Schedule +Ad26.COV2.S Booster","description":"Participants who initially received a single dose of placebo vaccine matching to Ad26.COV2.S IM injection on Day 1 in double blind phase and received non-mRNA vaccination outside of the trial or only 1 dose of mRNA vaccination or more than 2 doses of mRNA vaccination further received an Ad26.COV2 booster dose at a dose level of 5\\*10\\^10 vp at 1 year after the initial vaccination, with a minimum of 3 months after the last outside vaccination.","deathsNumAffected":0,"deathsNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"otherNumAffected":315,"otherNumAtRisk":943}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":18,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anaemia macrocytic","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anaemia vitamin B12 deficiency","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Blood loss anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Elephantiasis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Febrile neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Granulomatous lymphadenitis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypochromic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Immune thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":13,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Leukopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Microcytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nephrogenic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Splenic thrombosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spontaneous haematoma","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":24,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute cardiac event","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":14,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":7,"numAtRisk":21890},{"groupId":"EG002","numAffected":53,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arrhythmia supraventricular","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arteriosclerosis coronary artery","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":47,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrial tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrioventricular block","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrioventricular block second degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atrioventricular node dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac amyloidosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":12,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac disorder","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":19,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac failure acute","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac failure chronic","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":16,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac ventricular thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiogenic shock","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiopulmonary failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chronic left ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Congestive cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cor pulmonale","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":35,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Coronary artery occlusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Coronary artery stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Coronary artery thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Left ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mitral valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mitral valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mitral valve prolapse","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mitral valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":23,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myocarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pericarditis constrictive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Right ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sinus bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sinus node dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Stress cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Supraventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tachycardia paroxysmal","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tricuspid valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hydrocele","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertrophic cardiomyopathy","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pseudoxanthoma elasticum","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rathke's cleft cyst","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Skeletal dysplasia","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tympanic membrane perforation","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vertigo positional","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Adrenal insufficiency","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Basedow's disease","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endocrine disorder","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Goitre","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperparathyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperparathyroidism secondary","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperthyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thyroid mass","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Blindness","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diplopia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endocrine ophthalmopathy","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Glaucoma","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Macular degeneration","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Retinal artery embolism","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Retinal vascular thrombosis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Retinal vein thrombosis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ulcerative keratitis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal adhesions","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal compartment syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal distension","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal incarcerated hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal strangulated hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal wall disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal wall haematoma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute abdomen","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anal stenosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colitis ulcerative","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Crohn's disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diaphragmatic hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diverticulum intestinal haemorrhagic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Duodenal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Duodenal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Duodenal ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Enterocolitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Epiploic appendagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Food poisoning","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gallstone ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastric ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastric ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastritis alcoholic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastritis haemorrhagic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haematemesis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haematochezia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hernial eventration","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hiatus hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hiatus hernia, obstructive","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ileus paralytic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Impaired gastric emptying","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Incarcerated inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Incarcerated umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":14,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Inguinal hernia strangulated","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Internal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal ischaemia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal mass","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":23,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal pseudo-obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Large intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Large intestine perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Large intestine polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lower gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lumbar hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mallory-Weiss syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Melaena","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mesenteric panniculitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mesenteric vein thrombosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Obstructive pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal achalasia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal stenosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal varices haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":12,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatitis relapsing","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peptic ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peptic ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peptic ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumatosis intestinalis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Retroperitoneal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":16,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Upper gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Accidental death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":23,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Complication associated with device","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cyst","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":59,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Drowning","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Drug withdrawal syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gait disturbance","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Generalised oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Illness","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Implant site inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Multiple organ dysfunction syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pelvic mass","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Procedural failure","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Stent-graft endoleak","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sudden cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Systemic inflammatory response syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Biliary dyskinesia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Biliary tract disorder","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholangitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholangitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":18,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":19,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholecystitis chronic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholecystocholangitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":32,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dilatation intrahepatic duct acquired","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Drug-induced liver injury","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatitis alcoholic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatitis cholestatic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperbilirubinaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ischaemic hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Jaundice cholestatic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Liver injury","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Portal vein thrombosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"ABO incompatibility","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Allergy to chemicals","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anaphylactic reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anaphylactic shock","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Drug hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sarcoidosis","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal wall abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abscess neck","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abscess soft tissue","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute hepatitis B","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":21898},{"groupId":"EG001","numAffected":8,"numAtRisk":21890},{"groupId":"EG002","numAffected":54,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Appendicitis perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthritis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthritis gonococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthritis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atypical pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bacterial diarrhoea","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bacterial food poisoning","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bacterial sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Biliary sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Biliary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Brain abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bullous erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bursitis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":21898},{"groupId":"EG001","numAffected":53,"numAtRisk":21890},{"groupId":"EG002","numAffected":146,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"COVID-19 pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":21898},{"groupId":"EG001","numAffected":45,"numAtRisk":21890},{"groupId":"EG002","numAffected":105,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Campylobacter infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cardiac valve abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cavernous sinus thrombosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":23,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cholecystitis infective","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chronic sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Clostridium difficile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colonic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Complicated appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Creutzfeldt-Jakob disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cytomegalovirus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dengue fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dengue haemorrhagic fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetic foot infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diarrhoea infectious","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":15,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diverticulitis intestinal perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dysentery","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Encephalitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endocarditis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Enterobacter sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Epiglottitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Epstein-Barr virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Escherichia bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Escherichia infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Escherichia urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Eye abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Focal peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":17,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastroenteritis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal bacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Genital abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"HIV infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatitis B","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Herpes zoster meningitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Implant site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Infected bite","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Infective exacerbation of chronic obstructive airways disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Labyrinthitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Large intestine infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Laryngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Liver abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":11,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lung abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mastoiditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Medical device site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meningitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meningitis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meningitis cryptococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meningitis tuberculous","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meningitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Monkeypox","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mononucleosis syndrome","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neurosyphilis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Orchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":16,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pelvic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pelvic inflammatory disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Perichondritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Perineal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Periorbital cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Perirectal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peritoneal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peritonsillar abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pertussis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pharyngitis streptococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pilonidal disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Plasmodium vivax infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumocystis jirovecii pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":21898},{"groupId":"EG001","numAffected":13,"numAtRisk":21890},{"groupId":"EG002","numAffected":56,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia aspiration","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":18,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia legionella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia respiratory syncytial viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia staphylococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia streptococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonia viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pseudomembranous colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pseudomonal bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pseudomonas infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Psoas abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pyelonephritis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pyelonephritis chronic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rectal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Respiratory syncytial virus bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rhinovirus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Scrotal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":22,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Severe acute respiratory syndrome","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Soft tissue infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Staphylococcal bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Staphylococcal osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Subcutaneous abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Subdiaphragmatic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Suspected COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thyroglossal cyst infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tooth abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Typhoid fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Upper respiratory tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary tract candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":32,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary tract infection pseudomonal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Accidental exposure to product","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Accidental overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acetabulum fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anaemia postoperative","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anastomotic complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anastomotic ulcer haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Animal bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":14,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Aortic injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Brachial plexus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cervical vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chemical poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chest injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Comminuted fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Concussion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":12,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Exposure during pregnancy","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Face injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":20,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Foot fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Forearm fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Foreign body in gastrointestinal tract","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal anastomotic complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gun shot wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":11,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Incarcerated incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Incision site impaired healing","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intentional overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Jaw fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Joint dislocation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ligament injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ligament rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lower limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meniscus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Multiple fractures","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Multiple injuries","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Muscle rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nasal injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Patella fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pelvic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Periprosthetic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumothorax traumatic","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural bile leak","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural haematuria","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post procedural hypotension","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post vaccination syndrome","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post-traumatic neck syndrome","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post-traumatic pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prescribed overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Procedural intestinal perforation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Procedural nausea","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Procedural vomiting","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Seroma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Shunt occlusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Skin abrasion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Skin laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Soft tissue foreign body","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Soft tissue injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal cord injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Splenic injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Stab wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sternal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Subdural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tendon injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Testicular injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thermal burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thoracic vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":14,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tissue injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Toxicity to various agents","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Traumatic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Traumatic haemothorax","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Traumatic liver injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ulna fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ureteric anastomosis complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary retention postoperative","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vascular graft thrombosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vulvovaginal injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Wound dehiscence","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Wrist fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthroscopy","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Blood pressure increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carcinoembryonic antigen increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"HIV test positive","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haemoglobin decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Liver function test increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Micrococcus test positive","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Misleading laboratory test result","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neutrophil count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oxygen saturation decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Platelet count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulse absent","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"SARS-CoV-2 test positive","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thyroid function test abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cachexia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetic metabolic decompensation","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Histamine intolerance","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperglycaemic hyperosmolar nonketotic syndrome","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypernatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Obesity","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":17,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arthropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":11,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bursitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cervical spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Compartment syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dupuytren's contracture","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Flank pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Foot deformity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Fracture delayed union","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Immunoglobulin G4 related disease","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intervertebral disc degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":17,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Joint ankylosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Joint effusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meniscal degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myofascial pain syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Osteitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":54,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Osteolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Osteonecrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pain in jaw","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Polyarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rhabdomyolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rheumatoid arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":11,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Scoliosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal instability","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal synovial cyst","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spondylolisthesis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Synovial cyst","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Temporomandibular joint syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tendon disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tenosynovitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tenosynovitis stenosans","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Trigger finger","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vertebral foraminal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abdominal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acoustic neuroma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Adenocarcinoma pancreas","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Adenoid cystic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"B-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Benign neoplasm of thyroid gland","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bladder neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bladder squamous cell carcinoma stage unspecified","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bladder transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Brain cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Brain neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":32,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast cancer female","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast cancer in situ","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast cancer stage I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast cancer stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cancer pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carcinoid tumour pulmonary","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Central nervous system lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cervix carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chronic lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chronic myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Clear cell renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colon neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Colorectal adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diffuse large B-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ductal adenocarcinoma of pancreas","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endometrial adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endometrial cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ewing's sarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Follicular lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Follicular lymphoma stage I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Follicular lymphoma stage IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Follicular thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gammopathy","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrointestinal stromal tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gastrooesophageal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Glioblastoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hairy cell leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatic cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatic cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatobiliary neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatocellular carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intestinal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intraductal proliferative breast lesion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intraosseous meningioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Invasive ductal breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":10,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Invasive lobular breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Laryngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":12,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lung squamous cell carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lymphoplasmacytoid lymphoma/immunocytoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Malignant melanoma in situ","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Malignant melanoma stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Malignant neoplasm of unknown primary site","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Malignant pleural effusion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Meningioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Metastases to liver","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Metastases to lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Metastatic carcinoma of the bladder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Metastatic malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myelodysplastic syndrome","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myelofibrosis","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neoplasm of appendix","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neoplasm of orbit","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuroectodermal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuroendocrine carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuroendocrine carcinoma of the bladder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuroendocrine tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neurofibrosarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Non-small cell lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oropharyngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Oropharyngeal squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian cancer stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian germ cell teratoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian granulosa cell tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatic carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatic neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatic neuroendocrine tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Papillary renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Papillary thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Parathyroid tumour benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peritoneal mesothelioma malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pituitary tumour benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Plasma cell myeloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Plasma cell myeloma recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Polycythaemia vera","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":38,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostate cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostate cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostate cancer stage II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostate cancer stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Rectal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Schwannoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Skin cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Skin papilloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Squamous cell carcinoma of head and neck","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Squamous cell carcinoma of the tongue","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"T-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Testis cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Throat cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thymoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thyroid neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tongue neoplasm malignant stage unspecified","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tumour haemorrhage","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urethral cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":13,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Waldenstrom's macroglobulinaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Apallic syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ascending flaccid paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bell's palsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Brain stem thrombosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carotid artery aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carotid artery disease","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carotid artery dissection","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carotid artery occlusion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebral ischaemia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":8,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebral vasoconstriction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebral venous sinus thrombosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebrospinal fistula","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebrospinal fluid leakage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":6,"numAtRisk":21890},{"groupId":"EG002","numAffected":19,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cervical radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cognitive disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Coma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Complex regional pain syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Embolic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Facial paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Generalised tonic-clonic seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Guillain-Barre syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haemorrhagic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haemorrhagic transformation stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hemiplegia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hepatic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hyperglycaemic seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertensive encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Idiopathic intracranial hypertension","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intracranial aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intracranial mass","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ischaemic cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":45,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lacunar stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lumbar radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Metabolic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Migraine without aura","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Multiple sclerosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Myelopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nervous system disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuralgia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuralgic amyotrophy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Neuroglycopenia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Optic neuritis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Paraparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Partial seizures","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ruptured cerebral aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":15,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal cord compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spinal cord haematoma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Spondylitic myelopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":28,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tension headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Transient global amnesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":27,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Transverse sinus thrombosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Trigeminal neuralgia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uraemic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vertebrobasilar artery dissection","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abortion","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abortion incomplete","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abortion missed","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abortion of ectopic pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abortion spontaneous","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":21,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cephalhaematoma","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ectopic pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Foetal death","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Foetal growth abnormality","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Gestational diabetes","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"High risk pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pre-eclampsia","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Premature baby","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Premature labour","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Preterm premature rupture of membranes","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Stillbirth","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vanishing twin syndrome","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Device breakage","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Device dislocation","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Device failure","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Device power source issue","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Drug delivery system malfunction","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute psychosis","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Alcohol withdrawal syndrome","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bipolar disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Borderline personality disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Catatonia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Completed suicide","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Conversion disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Depression suicidal","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Intentional self-injury","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Major depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mania","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Mixed anxiety and depressive disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Panic attack","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Post-traumatic stress disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Schizoaffective disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Schizophrenia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Somatic symptom disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Substance abuse","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Substance dependence","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Substance use disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Substance-induced psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Suicidal ideation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Suicide attempt","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":4,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":16,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bladder outlet obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Bladder trabeculation","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Calculus urethral","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Calculus urinary","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"End stage renal disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertonic bladder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nephritic syndrome","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":31,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Nephrotic syndrome","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal cyst","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal haematoma","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Renal mass","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ureterolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":14,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urethral obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary bladder rupture","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Abnormal uterine bleeding","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acquired hydrocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Adenomyosis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Adnexa uteri mass","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":21,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast disorder","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Breast mass","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cervical dysplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Cystocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endometrial hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Endometriosis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Feminisation acquired","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Heavy menstrual bleeding","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian hyperstimulation syndrome","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Ovarian mass","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pelvic pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Premature menopause","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostatic disorder","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostatic haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Prostatomegaly","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Testicular torsion","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine disorder","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine polyp","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vaginal haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vaginal prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute respiratory distress syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":18,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Atelectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":25,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":9,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Emphysema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haemothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Idiopathic pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lung disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pharyngeal mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pleural mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pneumothorax spontaneous","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":21898},{"groupId":"EG001","numAffected":3,"numAtRisk":21890},{"groupId":"EG002","numAffected":50,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary hypertension","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary infarction","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pulmonary thrombosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Respiratory arrest","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":7,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Tonsillar ulcer","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Angioedema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Blister","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Decubitus ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetic foot","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Diabetic ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Drug eruption","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lipodystrophy acquired","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Subcutaneous emphysema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Miscarriage of partner","organSystem":"Social circumstances","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Organ donor","organSystem":"Social circumstances","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Physical assault","organSystem":"Social circumstances","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hospitalisation","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":4,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Arteriosclerosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":38,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Embolism venous","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":21898},{"groupId":"EG001","numAffected":2,"numAtRisk":21890},{"groupId":"EG002","numAffected":6,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertensive crisis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertensive emergency","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypertensive urgency","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":5,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Hypovolaemic shock","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Leriche syndrome","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Lymphoedema","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"May-Thurner syndrome","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Orthostatic hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral arterial occlusive disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral artery aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral artery aneurysm rupture","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral artery thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral ischaemia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral vascular disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Peripheral venous disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Phlebitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Shock","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thrombophlebitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":2,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vasospasm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Vena cava thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":1,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Venous thrombosis limb","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":3,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pancreatolithiasis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":0,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Pilonidal cyst","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":0,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Smear cervix abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":21898},{"groupId":"EG001","numAffected":1,"numAtRisk":21890},{"groupId":"EG002","numAffected":0,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Brain stem stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":0,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Aggression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":0,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]},{"term":"Thrombophlebitis of the right upper limb cephalic vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":21898},{"groupId":"EG001","numAffected":0,"numAtRisk":21890},{"groupId":"EG002","numAffected":0,"numAtRisk":43788},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0},{"groupId":"EG005","numAtRisk":0}]}],"otherEvents":[{"term":"Nausea(Solicited)","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":550,"numAtRisk":3356},{"groupId":"EG001","numAffected":363,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":968,"numAtRisk":22213},{"groupId":"EG004","numAffected":35,"numAtRisk":613},{"groupId":"EG005","numAffected":67,"numAtRisk":943}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":70,"numAtRisk":3356},{"groupId":"EG001","numAffected":22,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":20,"numAtRisk":22213},{"groupId":"EG004","numAffected":3,"numAtRisk":613},{"groupId":"EG005","numAffected":3,"numAtRisk":943}]},{"term":"Fatigue(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1420,"numAtRisk":3356},{"groupId":"EG001","numAffected":829,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":2589,"numAtRisk":22213},{"groupId":"EG004","numAffected":115,"numAtRisk":613},{"groupId":"EG005","numAffected":155,"numAtRisk":943}]},{"term":"Pyrexia(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":250,"numAtRisk":3356},{"groupId":"EG001","numAffected":12,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":169,"numAtRisk":22213},{"groupId":"EG004","numAffected":20,"numAtRisk":613},{"groupId":"EG005","numAffected":16,"numAtRisk":943}]},{"term":"Vaccination site erythema (Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":246,"numAtRisk":3356},{"groupId":"EG001","numAffected":134,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":325,"numAtRisk":22213},{"groupId":"EG004","numAffected":12,"numAtRisk":613},{"groupId":"EG005","numAffected":27,"numAtRisk":943}]},{"term":"Vaccination site pain(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1781,"numAtRisk":3356},{"groupId":"EG001","numAffected":595,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":3702,"numAtRisk":22213},{"groupId":"EG004","numAffected":134,"numAtRisk":613},{"groupId":"EG005","numAffected":201,"numAtRisk":943}]},{"term":"Vaccination site swelling(Solicited)","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":198,"numAtRisk":3356},{"groupId":"EG001","numAffected":51,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":316,"numAtRisk":22213},{"groupId":"EG004","numAffected":11,"numAtRisk":613},{"groupId":"EG005","numAffected":21,"numAtRisk":943}]},{"term":"Myalgia(Solicited)","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1246,"numAtRisk":3356},{"groupId":"EG001","numAffected":494,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":2140,"numAtRisk":22213},{"groupId":"EG004","numAffected":105,"numAtRisk":613},{"groupId":"EG005","numAffected":126,"numAtRisk":943}]},{"term":"Headache (Solicited)","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 24.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1454,"numAtRisk":3356},{"groupId":"EG001","numAffected":900,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":2220,"numAtRisk":22213},{"groupId":"EG004","numAffected":97,"numAtRisk":613},{"groupId":"EG005","numAffected":130,"numAtRisk":943}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":48,"numAtRisk":3356},{"groupId":"EG001","numAffected":70,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":153,"numAtRisk":22213},{"groupId":"EG004","numAffected":5,"numAtRisk":613},{"groupId":"EG005","numAffected":21,"numAtRisk":943}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 25.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":63,"numAtRisk":3356},{"groupId":"EG001","numAffected":70,"numAtRisk":3380},{"groupId":"EG002","numAtRisk":0},{"groupId":"EG003","numAffected":182,"numAtRisk":22213},{"groupId":"EG004","numAffected":4,"numAtRisk":613},{"groupId":"EG005","numAffected":17,"numAtRisk":943}]}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"Safety results are reported in AE section, hence not repeated again in OM section. As pre-specified in statistical analysis plan, data of efficacy OMs for OL booster phase was not collected and analyzed. As clinical development program has moved from \"Development\" to \"Life cycle management\" phase, scope and extent of open label analysis was reduced. Hence, data was not collected and analyzed for OMs of platelet count, Biomarkers With SARS-CoV-2 Infection \\& COVID-19 Severity Using RNA Sequencing."},"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation."},"pointOfContact":{"title":"SENIOR ADVISOR CLINICAL DEVELOPMENT","organization":"Janssen R&D US","email":"ClinicalTrialDisclosure@its.jnj.com","phone":"844-434-4210"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2022-04-15","uploadDate":"2024-03-28T13:15","filename":"Prot_002.pdf","size":11148443},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2021-07-20","uploadDate":"2024-03-28T13:15","filename":"SAP_003.pdf","size":3344492},{"typeAbbrev":"ICF","hasProtocol":false,"hasSap":false,"hasIcf":true,"label":"Informed Consent Form","date":"2022-05-18","uploadDate":"2024-03-28T13:14","filename":"ICF_004.pdf","size":436755}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09","removedCountries":["Philippines","Ukraine"],"submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2022-02-07","type":"ACTUAL"}}}},"interventionBrowseModule":{"meshes":[{"id":"D000090984","term":"Ad26COVS1"}],"ancestors":[{"id":"D000086663","term":"COVID-19 Vaccines"},{"id":"D014765","term":"Viral Vaccines"},{"id":"D014612","term":"Vaccines"},{"id":"D001688","term":"Biological Products"},{"id":"D045424","term":"Complex Mixtures"}]}},"hasResults":true}